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Midlife women, from 45-60, enter new challenges in life with various impacts 
on health and quality of life. Mental and stress-related illnesses are common 
causes for attending primary health care (PHC) and long-term sick leave. 
Today there are few educational opportunities, support or care for life going 
through the natural ageing and topics related to this transition period, which 
often coincides with menopause transition (MT). The identification of the 
prevalence of symptoms, prognostic factors and evaluating interventions for 
preventing stress-related illnesses, long-term sick leave, improve quality of 
life, and gaining further knowledge, is motivated. The overall aim of the 
present thesis was to obtain knowledge about; I) prevalence and severity of 
somatic, urogenital and psychological symptoms measured with the 
Menopause Rating Scale (MRS), II) the effect of group education intervention 
based on topics related to menopause transition in midlife women with focus 
on somatic, urogenital, psychological and psycho-social health, III) prognostic 
factors for health-related quality of life and work ability, and IV) the effect of 
group education or person-centered individual support in PHC on mental 
health, quality of life and sick leave in women aged 45-60 with stress-related 
symptoms.  
 
Study I  
The aim was to estimate the prevalence of somatic, urogenital and 
psychological symptoms in women aged 45–55 attending PHC and evaluate 
factors associated with severe symptoms. One hundred and thirty-one women 
were included in this cross-sectional study. Data was obtained from two self-
reported questionnaires, the MRS and the Montgomery-Asberg Depression 
Rating Scale (MADRS). The five most frequently reported MRS symptoms 
were; physical and mental exhaustion (73 %), depressive mood (66 %), sleep 
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were included in this cross-sectional study. Data was obtained from two self-
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(62 %). Moreover, more severe depression symptoms (MADRS) and 
increasing age were associated with more severe menopausal symptoms 
(MRS). A nomogram was constructed for assessing the probability for severity 
of menopause symptoms using these three factors. 
 
Study II   
This RCT, investigates whether group education about menopause transition 
to women in PHC can improve women’s menopausal symptoms and mental 
health. Midlife women (n=131), aged 45-55 years, were randomized to group 
education (n=64) or no intervention (n=67). The group education included two 
sessions with topics related to menopause transition. The MRS and MADRS 
were filled in at baseline and four months later. Main outcomes were change 
in MRS and MADRS over the four months. The intervention group 
experienced a slight reduction in symptoms while the control group mostly 
experienced the opposite.  
 
Study III 
This 6-year longitudinal cohort study investigated prognostic factors for future 
mental, physical, and urogenital health, as well as work ability in a population 
of women aged 45–55 years. Sixty-five percent (n = 71/110) of the women 
included in Study I could be followed up at 6 years. Prognostic factors for later 
health-related quality of life (SF36), work ability (yes/no) and hypertension 
(yes/no) were analysed by multivariate regression analyses. Living with a 
partner was associated with a better chance for good health, and having tertiary 
education was shown to be associated with poorer mental health after six years. 
 
Study IV 
This RCT, with a two-factor design including 368 women, evaluated the effect 
of group education as well as person-centred support in a PHC context on 
mental health issues and quality of life in women aged 45-60 with stress-related 
symptoms. The women were allocated to four groups: 1, group education (GE) 
2, GE and person-centered individual support (PCS) 3, PCS and 4, a control 
group. GE comprised four one and one half hour, weekly sessions, and PCS 
included five sessions with topics related to middle age, but adapted to the 
woman’s individual situation and based on the woman´s narratives, needs, 
resources and beliefs. The effect of the interventions were followed up at 6 and 
12 months after baseline. 
 
Conclusion 
This thesis has described and identified factors associated with the transition 
period in women between the ages of 45 and 60, identified prognostics factors 
for later work ability and quality of life, as well as positive effects on health-
Lena Rindner 
5 
related quality of life, physical, urogenital, and mental symptoms of a person-
centered intervention using the district nurse’s competence and assignment in 
PHC and an interdisciplinary collaboration with midwife. 
 
Keywords  
Menopause transition, menopause, women’s health, mental health, urogenital 
health, quality of life, local oestrogen deficiency symptoms, stress, sleep, 
hypertension, vaginal dryness, social support, depression, mental illness, 
common mental disorders, district nurse, education, Menopause Rating Scale, 
primary health care, person centered care 
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SAMMANFATTNING PÅ SVENSKA 
Medelålders kvinnor, från 45–60, går in i nya utmaningar i livet och en 
period av stora bio-psykosociala förändringar med varierande inverkan 
på hälsa och livskvalitet. Psykiska och stressrelaterade sjukdomar är 
vanliga orsaker till besök i primärvården och långvarig sjukfrånvaro.  
Idag finns det få utbildningsmöjligheter, stöd och behandling om det naturliga 
åldrandet och om ämnen relaterade till denna övergångsperiod, vilken ofta 
sammanfaller med klimakteriet. Identifiering av förekomst av symtom, 
prognostiska faktorer och utvärdering av insatser för att förebygga 
stressrelaterade sjukdomar och långvarig sjukfrånvaro och förbättra 
livskvaliteten är motiverande. Syftet med avhandlingen var att få kunskap om, 
I) prevalens och svårighetsgrad av somatiska, urogenitala och psykologiska 
symtom med frågeformuläret Menopause Rating Scale (MRS), II) effekten av 
grupputbildningsinsats baserat på ämnen relaterade till klimakteriet till kvinnor 
45-55 år med fokus på somatisk, urogenital, psykologisk och psykosocial 
hälsa, III) prognostiska faktorer för hälsorelaterad livskvalitet och 
arbetsförmåga, och IV) effekten av grupputbildning och personcentrerat 
individuellt stöd i primärvården avseende mental hälsa, livskvalitet och 
sjukfrånvaro hos kvinnor i åldern 45–60 år med stressrelaterade symtom. 
 
Studie I 
Syftet var att uppskatta förekomsten av somatiska, urogenitala och 
psykologiska symtom hos kvinnor i åldrarna 45–55 i primärvården och 
utvärdera faktorer som är associerade med svåra symtom.  I en tvärsnittsstudie 
inkluderades 131 kvinnor. Två självskattningsformulär användes, MRS och 
Montgomery-Asberg Depression Rating Scale (MADRS). De fem mest 
rapporterade MRS-symtomen var; fysisk och mental utmattning (73%), 
depressivt humör (66%), sömnproblem (66%), värmevallningar (66%), 
muskel- och ledproblem och sexuella problem (62%). Dessutom var 
allvarligare depressionssymtom (MADRS) och ökande ålder associerade med 
svårare menopausala symtom (MRS). Dessa tre faktorer användes för att 




Syftet med studien var att undersöka om gruppundervisning om ämnen 
relaterade till klimakteriet för kvinnor i primärvården kan förbättra kvinnors 
menopausala symptom och minska depression. I en RCT-studie inkluderade 
totalt 131 kvinnor och randomiserades till gruppundervisning eller ingen 
intervention. Gruppinterventionen inkluderade två, 120 minuters 
utbildningssessioner med ämnen relaterade till klimakteriet. Två frågeformulär 
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MRS och MADRS besvarades vid baseline och fyra månader senare. 
Huvudresultat indikerade förändring i MRS- och MADRS-poäng efter fyra 
månader. Interventionsgruppen upplevde en liten minskning av symtomen, 
medan kontrollgruppen upplevde motsatsen.  
 
Studie III 
I en 6-årig longitudinell kohortstudie undersöktes prognostiska faktorer för 
framtida fysisk, urogenital och mental hälsa samt arbetsförmåga hos kvinnor 
45–55 år. Sextiofem procent (n = 71/110) av kvinnorna som inkluderades i 
studie I kunde följas upp vid 6 år. Prognostiska faktorer för senare 
hälsorelaterad livskvalitet (SF36), arbetsförmåga (ja / nej) och hypertoni (ja / 
nej) analyserades med multivariabla regressionsanalyser. Studien indikerade 
att bo med en partner var förknippad med en bättre chans att ha god hälsa 
medan att ha högre utbildning visade sig vara förknippat med sämre mental 
hälsa efter 6 år. 
 
Studie IV 
I en RCT studie med en tvåfaktordesign inkluderade 368 kvinnor med syfte att 
utvärderade effekten av grupputbildning och individuellt personcentrerat stöd 
i primärvården på psykisk ohälsa och livskvalitet hos kvinnor i åldrarna 45–60 
med stressrelaterade symtom. Kvinnorna fördelades i fyra grupper: 1), 
grupputbildning (GE) 2), GE och personcentrerat individuellt stöd (PCS) 3), 
PCS och 4), kontrollgrupp. GE bestod av fyra stycken en och en halv timmas 
sessioner och PCS inkluderade fem sessioner med ämnen relaterade till hälsan 
”mitt i livet” som var anpassade till kvinnans individuella situation och baserat 
på kvinnans berättelser, behov, resurser och övertygelser. Effekten av 
interventionerna följdes upp 6 och 12 månader efter baseline. 
 
Slutsats 
Avhandlingen har beskrivit och identifierat faktorer associerade med 
övergångsåldern hos kvinnor mellan 45 och 60 år, identifierat prognostiska 
faktorer för senare arbetsförmåga och livskvalitet, samt visat positiva effekter 
på hälsorelaterad livskvalitet, fysisk, urogenital, och psykiska symtom av 
personcentrerat individuellt samtal där distriktssköterskans kompetens och 
hälsofrämjande uppdrag i primärvården används, samt ett interdisciplinärt 
samarbete med barnmorska. 
  
Women’s health in midlife - a person-centered approach in primary care  
6 
SAMMANFATTNING PÅ SVENSKA 
Medelålders kvinnor, från 45–60, går in i nya utmaningar i livet och en 
period av stora bio-psykosociala förändringar med varierande inverkan 
på hälsa och livskvalitet. Psykiska och stressrelaterade sjukdomar är 
vanliga orsaker till besök i primärvården och långvarig sjukfrånvaro.  
Idag finns det få utbildningsmöjligheter, stöd och behandling om det naturliga 
åldrandet och om ämnen relaterade till denna övergångsperiod, vilken ofta 
sammanfaller med klimakteriet. Identifiering av förekomst av symtom, 
prognostiska faktorer och utvärdering av insatser för att förebygga 
stressrelaterade sjukdomar och långvarig sjukfrånvaro och förbättra 
livskvaliteten är motiverande. Syftet med avhandlingen var att få kunskap om, 
I) prevalens och svårighetsgrad av somatiska, urogenitala och psykologiska 
symtom med frågeformuläret Menopause Rating Scale (MRS), II) effekten av 
grupputbildningsinsats baserat på ämnen relaterade till klimakteriet till kvinnor 
45-55 år med fokus på somatisk, urogenital, psykologisk och psykosocial 
hälsa, III) prognostiska faktorer för hälsorelaterad livskvalitet och 
arbetsförmåga, och IV) effekten av grupputbildning och personcentrerat 
individuellt stöd i primärvården avseende mental hälsa, livskvalitet och 
sjukfrånvaro hos kvinnor i åldern 45–60 år med stressrelaterade symtom. 
 
Studie I 
Syftet var att uppskatta förekomsten av somatiska, urogenitala och 
psykologiska symtom hos kvinnor i åldrarna 45–55 i primärvården och 
utvärdera faktorer som är associerade med svåra symtom.  I en tvärsnittsstudie 
inkluderades 131 kvinnor. Två självskattningsformulär användes, MRS och 
Montgomery-Asberg Depression Rating Scale (MADRS). De fem mest 
rapporterade MRS-symtomen var; fysisk och mental utmattning (73%), 
depressivt humör (66%), sömnproblem (66%), värmevallningar (66%), 
muskel- och ledproblem och sexuella problem (62%). Dessutom var 
allvarligare depressionssymtom (MADRS) och ökande ålder associerade med 
svårare menopausala symtom (MRS). Dessa tre faktorer användes för att 




Syftet med studien var att undersöka om gruppundervisning om ämnen 
relaterade till klimakteriet för kvinnor i primärvården kan förbättra kvinnors 
menopausala symptom och minska depression. I en RCT-studie inkluderade 
totalt 131 kvinnor och randomiserades till gruppundervisning eller ingen 
intervention. Gruppinterventionen inkluderade två, 120 minuters 
utbildningssessioner med ämnen relaterade till klimakteriet. Två frågeformulär 
Lena Rindner 
7 
MRS och MADRS besvarades vid baseline och fyra månader senare. 
Huvudresultat indikerade förändring i MRS- och MADRS-poäng efter fyra 
månader. Interventionsgruppen upplevde en liten minskning av symtomen, 
medan kontrollgruppen upplevde motsatsen.  
 
Studie III 
I en 6-årig longitudinell kohortstudie undersöktes prognostiska faktorer för 
framtida fysisk, urogenital och mental hälsa samt arbetsförmåga hos kvinnor 
45–55 år. Sextiofem procent (n = 71/110) av kvinnorna som inkluderades i 
studie I kunde följas upp vid 6 år. Prognostiska faktorer för senare 
hälsorelaterad livskvalitet (SF36), arbetsförmåga (ja / nej) och hypertoni (ja / 
nej) analyserades med multivariabla regressionsanalyser. Studien indikerade 
att bo med en partner var förknippad med en bättre chans att ha god hälsa 
medan att ha högre utbildning visade sig vara förknippat med sämre mental 
hälsa efter 6 år. 
 
Studie IV 
I en RCT studie med en tvåfaktordesign inkluderade 368 kvinnor med syfte att 
utvärderade effekten av grupputbildning och individuellt personcentrerat stöd 
i primärvården på psykisk ohälsa och livskvalitet hos kvinnor i åldrarna 45–60 
med stressrelaterade symtom. Kvinnorna fördelades i fyra grupper: 1), 
grupputbildning (GE) 2), GE och personcentrerat individuellt stöd (PCS) 3), 
PCS och 4), kontrollgrupp. GE bestod av fyra stycken en och en halv timmas 
sessioner och PCS inkluderade fem sessioner med ämnen relaterade till hälsan 
”mitt i livet” som var anpassade till kvinnans individuella situation och baserat 
på kvinnans berättelser, behov, resurser och övertygelser. Effekten av 
interventionerna följdes upp 6 och 12 månader efter baseline. 
 
Slutsats 
Avhandlingen har beskrivit och identifierat faktorer associerade med 
övergångsåldern hos kvinnor mellan 45 och 60 år, identifierat prognostiska 
faktorer för senare arbetsförmåga och livskvalitet, samt visat positiva effekter 
på hälsorelaterad livskvalitet, fysisk, urogenital, och psykiska symtom av 
personcentrerat individuellt samtal där distriktssköterskans kompetens och 
hälsofrämjande uppdrag i primärvården används, samt ett interdisciplinärt 
samarbete med barnmorska. 
  
Women’s health in midlife - a person-centered approach in primary care  
8 
LIST OF PAPERS  
This thesis is based on the following studies, referred to in the text by their 
Roman numerals. Copyright belongs to the publisher or journals and are used 
with permission in this thesis. 
 
I. Rindner L, Strömme G, Nordeman L, Wigren M, Hange D, 
Gunnarsson R, Rembeck G. Prevalence of somatic and urogenital 
symptoms as well as psychological health in women aged 45 to 55 
attending primary health care: a cross-sectional study. BMC Womens 
Health. 2017 Dec 8;17 (1):128.  
II. Rindner L, Strömme G, Nordeman L, Hange D, Gunnarsson R, 
Rembeck G. Reducing menopausal symptoms for women during the 
menopause transition using group education in a primary health care 
setting - a randomized controlled trial. Maturitas 2017 Apr:98: 14-19.  
III. Rindner L, Nordeman L, Strömme G, Prembeck Å, Svenningsson I, 
Hange D, Gunnarsson R, Rembeck G. Prognostic factors for future 
mental, physical, and urogenital health and work ability in women, 
45–55 years. A six-year prospective longitudinal cohort study. BMC 
Womens Health. 2020. 20:171.  
IV. Rindner L, Nordeman L, Strömme G, Hange D, Gunnarsson R, 
Rembeck G. Effect of primary care education on mental health and 
quality of life in women 45-60 years with stress-related symptoms. A 






Sammanfattning på svenska .......................................................................... 6 
List of papers ................................................................................................ 8 
Contents ........................................................................................................ 9 
Abbreviations .............................................................................................. 12 
Definitions in short ..................................................................................... 15 
My journey .................................................................................................. 16 
Min resa ...................................................................................................... 17 
Introduction ............................................................................................... 19 
Women’s health in midlife.......................................................................... 19 
Prevalence of symptoms ............................................................................. 19 
Psycho-social health ................................................................................... 19 
Stress-related illness ................................................................................... 20 
Impact on work ability ................................................................................ 20 
Health-related Quality of Life ..................................................................... 21 
The Transition ............................................................................................. 22 
The menopause transition ........................................................................... 22 
Menopause definition ................................................................................. 22 
Menopause transition stages and phases ..................................................... 23 
Common signs and symptoms in midlife .................................................... 26 
Vasomotor symptoms ................................................................................. 26 
Sleep………… ............................................................................................ 26 
Muscle and joint pain .................................................................................. 27 
Cardiovascular health ................................................................................. 27 
Urogenital symptoms .................................................................................. 27 
Urinary incontinence ................................................................................... 27 
Vaginal atrophy and local oestrogen deficiency symptoms ........................ 28 
Mental health .............................................................................................. 28 
Management in primary health care ........................................................... 29 
District nurse ............................................................................................... 30 
Women’s health in midlife - a person-centered approach in primary care  
8 
LIST OF PAPERS  
This thesis is based on the following studies, referred to in the text by their 
Roman numerals. Copyright belongs to the publisher or journals and are used 
with permission in this thesis. 
 
I. Rindner L, Strömme G, Nordeman L, Wigren M, Hange D, 
Gunnarsson R, Rembeck G. Prevalence of somatic and urogenital 
symptoms as well as psychological health in women aged 45 to 55 
attending primary health care: a cross-sectional study. BMC Womens 
Health. 2017 Dec 8;17 (1):128.  
II. Rindner L, Strömme G, Nordeman L, Hange D, Gunnarsson R, 
Rembeck G. Reducing menopausal symptoms for women during the 
menopause transition using group education in a primary health care 
setting - a randomized controlled trial. Maturitas 2017 Apr:98: 14-19.  
III. Rindner L, Nordeman L, Strömme G, Prembeck Å, Svenningsson I, 
Hange D, Gunnarsson R, Rembeck G. Prognostic factors for future 
mental, physical, and urogenital health and work ability in women, 
45–55 years. A six-year prospective longitudinal cohort study. BMC 
Womens Health. 2020. 20:171.  
IV. Rindner L, Nordeman L, Strömme G, Hange D, Gunnarsson R, 
Rembeck G. Effect of primary care education on mental health and 
quality of life in women 45-60 years with stress-related symptoms. A 






Sammanfattning på svenska .......................................................................... 6 
List of papers ................................................................................................ 8 
Contents ........................................................................................................ 9 
Abbreviations .............................................................................................. 12 
Definitions in short ..................................................................................... 15 
My journey .................................................................................................. 16 
Min resa ...................................................................................................... 17 
Introduction ............................................................................................... 19 
Women’s health in midlife.......................................................................... 19 
Prevalence of symptoms ............................................................................. 19 
Psycho-social health ................................................................................... 19 
Stress-related illness ................................................................................... 20 
Impact on work ability ................................................................................ 20 
Health-related Quality of Life ..................................................................... 21 
The Transition ............................................................................................. 22 
The menopause transition ........................................................................... 22 
Menopause definition ................................................................................. 22 
Menopause transition stages and phases ..................................................... 23 
Common signs and symptoms in midlife .................................................... 26 
Vasomotor symptoms ................................................................................. 26 
Sleep………… ............................................................................................ 26 
Muscle and joint pain .................................................................................. 27 
Cardiovascular health ................................................................................. 27 
Urogenital symptoms .................................................................................. 27 
Urinary incontinence ................................................................................... 27 
Vaginal atrophy and local oestrogen deficiency symptoms ........................ 28 
Mental health .............................................................................................. 28 
Management in primary health care ........................................................... 29 
District nurse ............................................................................................... 30 
Women’s health in midlife - a person-centered approach in primary care  
10 
Person-centered care ................................................................................... 30 
Patient education ......................................................................................... 31 
Ethics .......................................................................................................... 33 
Aims ........................................................................................................... 34 
General aims ............................................................................................... 34 
Specific aims ............................................................................................... 34 
Patients and Methods ............................................................................... 35 
Study designs, selection of participants and inclusion (I, II, III, IV) .......... 35 
Data collection (I, II, III, IV) ...................................................................... 38 
Personal factors (I, II, III, IV) ..................................................................... 38 
Pharmacologic treatment ............................................................................ 39 
Health measurments .................................................................................... 40 
Randomization procedure (Studies II, IV) .................................................. 42 
Interventions (II, IV) ................................................................................... 42 
Statistical analysis (I, II, III, IV) ................................................................. 46 
Between group comparison (I, II, IV) ......................................................... 46 
Prevalence of severe menopausal symptoms (I) ......................................... 47 
Results ........................................................................................................ 50 
Result study I .............................................................................................. 52 
Factors associated with menopausal symptoms as measured with MRS.... 56 
Result study II ............................................................................................. 59 
Result study III ........................................................................................... 62 
Cardiovascular symptoms at the 6-year follow-up ..................................... 63 
Changes in health at the 6-year follow-up .................................................. 63 
Predictors for good health at the 6-year follow-up ..................................... 64 
Result study IV ........................................................................................... 68 
Changes in health at 6 and 12 months. ....................................................... 68 
Effect of GE and PCS at 6 and 12 months. ................................................. 68 
Discussion .................................................................................................. 69 
Methodological aspects .............................................................................. 70 
Study design and study population (I, II, III, IV) ....................................... 70 
Lena Rindner 
11 
Gender (I, II, III, IV) ................................................................................... 70 
Measurements (I, II, III, IV) ....................................................................... 71 
Interventions (II, IV) ................................................................................... 71 
Statistical analysis (I, II, III, IV) ................................................................. 72 
Somatic, psychological, and urogenital symptoms and factors associated with 
severe symptoms in women (I). .................................................................. 73 
Group education for women about the menopause transition to improve their 
physical and mental ill-health (II). .............................................................. 75 
Prognostic factors for future mental, physical and urogenital health as well 
as work ability in women 45–55 (III). ........................................................ 75 
The effect of group education and person-centred support in a primary health 
care context on mental health issues and quality of life (IV). ..................... 77 
District nurse role in primary health care.................................................... 80 
Conclusion ................................................................................................. 81 
Future perspectives ................................................................................... 82 
Acknowledgements ................................................................................... 83 




Women’s health in midlife - a person-centered approach in primary care  
10 
Person-centered care ................................................................................... 30 
Patient education ......................................................................................... 31 
Ethics .......................................................................................................... 33 
Aims ........................................................................................................... 34 
General aims ............................................................................................... 34 
Specific aims ............................................................................................... 34 
Patients and Methods ............................................................................... 35 
Study designs, selection of participants and inclusion (I, II, III, IV) .......... 35 
Data collection (I, II, III, IV) ...................................................................... 38 
Personal factors (I, II, III, IV) ..................................................................... 38 
Pharmacologic treatment ............................................................................ 39 
Health measurments .................................................................................... 40 
Randomization procedure (Studies II, IV) .................................................. 42 
Interventions (II, IV) ................................................................................... 42 
Statistical analysis (I, II, III, IV) ................................................................. 46 
Between group comparison (I, II, IV) ......................................................... 46 
Prevalence of severe menopausal symptoms (I) ......................................... 47 
Results ........................................................................................................ 50 
Result study I .............................................................................................. 52 
Factors associated with menopausal symptoms as measured with MRS.... 56 
Result study II ............................................................................................. 59 
Result study III ........................................................................................... 62 
Cardiovascular symptoms at the 6-year follow-up ..................................... 63 
Changes in health at the 6-year follow-up .................................................. 63 
Predictors for good health at the 6-year follow-up ..................................... 64 
Result study IV ........................................................................................... 68 
Changes in health at 6 and 12 months. ....................................................... 68 
Effect of GE and PCS at 6 and 12 months. ................................................. 68 
Discussion .................................................................................................. 69 
Methodological aspects .............................................................................. 70 
Study design and study population (I, II, III, IV) ....................................... 70 
Lena Rindner 
11 
Gender (I, II, III, IV) ................................................................................... 70 
Measurements (I, II, III, IV) ....................................................................... 71 
Interventions (II, IV) ................................................................................... 71 
Statistical analysis (I, II, III, IV) ................................................................. 72 
Somatic, psychological, and urogenital symptoms and factors associated with 
severe symptoms in women (I). .................................................................. 73 
Group education for women about the menopause transition to improve their 
physical and mental ill-health (II). .............................................................. 75 
Prognostic factors for future mental, physical and urogenital health as well 
as work ability in women 45–55 (III). ........................................................ 75 
The effect of group education and person-centred support in a primary health 
care context on mental health issues and quality of life (IV). ..................... 77 
District nurse role in primary health care.................................................... 80 
Conclusion ................................................................................................. 81 
Future perspectives ................................................................................... 82 
Acknowledgements ................................................................................... 83 








AUC Aera Under Curve 
AUDIT Alcohol Use Disorders Identification Test 
CC Complete Case  
CG Control group 
CMD Common mental disorders 
CVD Cardiovascular disease 
DN District Nurse 
EMAS European Menopause and Andropause Society 
FMP  Final Menstrual Period 
GE Group Education  
GI Group Intervention  
HADS Hospital Anxiety and Depression Scale 
HRQoL  Health Related Quality of Life 
ICD-10 International statistical classification of diseases and related health 
problems 
IQ Inter Quartile Range 
ITT Intention-to-treat 
LDL Low Density Lipoprotein 
LOD Local oestrogen deficiency 
MADRS Montgomery-Asberg Depression Rating Scale 
Md  Median 
MHT  Menopause Hormone Therapy 
MRS Menopause Rating Scale 
MT Menopause Transition  
MTE Menopause Transition Education  
Lena Rindner 
13 
OECD Organisation for Economic Co-operation and Development 
PCC Person-centered care 
PCS Person-centered individual support 
PHC  Primary health care 
PP Per-protocol  
PSS-14 Perceived Stress Scale 
QoL  Quality of Life 
RCT  Randomized Controlled Trial 
 SD Standard deviation  
s-ED Self-rated Exhaustion Disorder Scale 
SF36 36-item Short Form Health Survey 
 PF Physical functioning 
  RF Physical functioning 
  GH General health 
  SF Social functioning 
  RE Role emotional 
  VT Vitality 
 MH Mental health 
 PCS Physical component summary score comprising: PF, RP, BP, GH 
 MCS Mental component summary score comprising: VT, SF, RE, MH 
SoS  The Swedish National Board of Health and Welfare 
STRAW  The Stages of the Reproductive Aging Workshop 
SWAN  Study of Women’s Health Across the Nation 
UI Urinary incontinence 
VAS  Visual analogue scale 
VIF Variance inflator factor 
VMS Vasomotor symptoms 




AUC Aera Under Curve 
AUDIT Alcohol Use Disorders Identification Test 
CC Complete Case  
CG Control group 
CMD Common mental disorders 
CVD Cardiovascular disease 
DN District Nurse 
EMAS European Menopause and Andropause Society 
FMP  Final Menstrual Period 
GE Group Education  
GI Group Intervention  
HADS Hospital Anxiety and Depression Scale 
HRQoL  Health Related Quality of Life 
ICD-10 International statistical classification of diseases and related health 
problems 
IQ Inter Quartile Range 
ITT Intention-to-treat 
LDL Low Density Lipoprotein 
LOD Local oestrogen deficiency 
MADRS Montgomery-Asberg Depression Rating Scale 
Md  Median 
MHT  Menopause Hormone Therapy 
MRS Menopause Rating Scale 
MT Menopause Transition  
MTE Menopause Transition Education  
Lena Rindner 
13 
OECD Organisation for Economic Co-operation and Development 
PCC Person-centered care 
PCS Person-centered individual support 
PHC  Primary health care 
PP Per-protocol  
PSS-14 Perceived Stress Scale 
QoL  Quality of Life 
RCT  Randomized Controlled Trial 
 SD Standard deviation  
s-ED Self-rated Exhaustion Disorder Scale 
SF36 36-item Short Form Health Survey 
 PF Physical functioning 
  RF Physical functioning 
  GH General health 
  SF Social functioning 
  RE Role emotional 
  VT Vitality 
 MH Mental health 
 PCS Physical component summary score comprising: PF, RP, BP, GH 
 MCS Mental component summary score comprising: VT, SF, RE, MH 
SoS  The Swedish National Board of Health and Welfare 
STRAW  The Stages of the Reproductive Aging Workshop 
SWAN  Study of Women’s Health Across the Nation 
UI Urinary incontinence 
VAS  Visual analogue scale 
VIF Variance inflator factor 
VMS Vasomotor symptoms 
Women’s health in midlife - a person-centered approach in primary care  
14 
WHO  World Health Organization 
Lena Rindner 
15 
DEFINITIONS IN SHORT 
  
Climacteric period  The period in life of natural ageing processes 
with hormonal changes from a reproductive 
to non-reproductive stage and is often used 
synonymously with peri-menopause. 
Menopause  The last menstruation in a woman´s life and 
is known as the Final Menstrual Period 
(FMP), marked by the absence of menses for 
12 months without a pathologic cause. 
Menopause transition  A universal part of a natural ageing process in 
women’s lives including a period of 
physiological changes. Defined as a period of 
about five years before and five years after the 
last menstruation, it marks the end of a 
woman's reproductive years including 
hormonal changes as well as bio-psycho-
social changes.  
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MY JOURNEY 
My interest in the subject awakened when I, in my clinical work as a district 
nurse in a primary health care centre, daily met women in midlife” with 
questions and thoughts about physical and mental symptoms. Many of these 
issues related to ageing and were natural changes in this phase of life, but gave 
rise to anxiety and ill health. The women did not feel ill but neither did they 
feel well, and did not know where to turn for care. I discovered a lack of 
response from health care to these women, and insufficient access to 
knowledge and information about this phase in their lives. I also discovered a 
lack of knowledge about care and treatment from a bio-psycho-social 
perspective for women 45-60. 
 
Thoughts arose of a care unit providing information, discussions, and 
instruction such as schoolgirls receive about puberty, similar to my work as a 
school nurse. Starting something similar for women who have reached 
menopausal age could be beneficial, based on a bio-psycho-social approach. 
I was introduced to midwife Gunilla Strömme, who had similar thoughts about 
women's mental, urogenital, and somatic health in midlife and about illness 
prevention. To start a women's health clinic in PHC, we felt it necessary to 
confirm the need for such a clinic, which was the start of our research in this 
area: women's mental, urogenital and somatic health in midlife” from a bio-
psycho-social perspective”.  
 
My interest in illness prevention and health promotion work is strong. The 
thesis evaluates the prevalence and prognostic factors as well as the effects of 
promoting health prevention and health factors in midlife by offering 
counselling, person-centered individual conversations, and education on 
topics related to menopause, based on a bio-psycho-social strategy for women 
45-60 in primary care.  
 
This thesis aims to improve knowledge about advice, support, and treatment 
for women 45-60 from a person-centered approach with a bio-psycho-social 
perspective, and with a health-promoting view of women's situations, mental, 
urogenital, somatic symptoms, and psychosocial health. Moreover, the aim 
was to improve women's quality of life and increase awareness of management 




Min resa  
Intresset för ämnet väcktes när jag i mitt kliniska arbete som 
distriktssjuksköterska på vårdcentralen dagligen träffade kvinnor ”mitt-i-
livet” med frågor och funderingar om fysiska och psykiska symtom, om 
förändringar i kroppen och om måendet. Många av dessa frågor tillhörde det 
naturliga åldrandet och var naturliga förändringar i denna fas i livet, men gav 
upphov till oro och ökad ohälsa för den enskilda kvinnan. Kvinnorna kände sig 
inte sjuka, men de kände sig inte heller bra och visste inte vart de skulle vända 
sig för att söka vård. Jag upptäckte bristande bemötande från vården och 
otillräcklig information om denna fas i livet. Jag upptäckte också att det fanns 
en kunskapsbrist om vård och behandling ur ett bio-psyko-socialt perspektiv 
till kvinnor i livsfasen 45–60 år.  
 
Då kom tankarna om att det skulle finnas en mottagning på vårdcentralen där 
kvinnan får information, råd och stöd liknande den information som 
tonårstjejer får i skolan om pubertetsutveckling, likt den jag gav under mitt 
arbete som skolsköterska. Att starta något liknande för kvinnor som kommit i 
den ålder som ofta sammanfaller med klimakteriet kanske vore bra och utifrån 
ett bio-psyko-socialt perspektiv. Jag blev genom en genomsam kontakt 
presenterad för barnmorskan Gunilla Strömme. Hon hade liknande tankar som 
jag om hälsoförebyggande prevention för kvinnors somatiska, urogenitala och 
psykiska hälsa mitt-i-livet. För att starta en kvinnohälsomottagning på 
vårdcentralen behövde vi bekräfta behovet av en sådan mottagning och det 
blev starten för vår forskning inom detta område; ”Kvinnors somatiska, 
urogenitala och psykiska hälsa mitt-i-livet ur ett bio-psyko-socialt perspektiv”. 
 
Mitt intresse för hälsoförebyggande och hälsofrämjande arbete är stort. 
Denna avhandling syftar till att förbättra kunskapen om råd, stöd och 
behandling för kvinnor 45–60 utifrån personcentrerad vård med ett bio-psyko-
socialt perspektiv och med en helhetssyn på kvinnors situation, symtom och 
psykosociala hälsa. Genom att erbjuda grupputbildning och personcentrade 
individuella samtal utifrån ett bio-psyko-socialt förhållningsätt för kvinnor 
mitt-i-livet är förhoppningen att kunna förbättra livskvalitet, öka 
medvetenheten om copingstrategier och livsstil med positiv effekt på hälsan. 
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Midlife is a natural phase in life, and a time of bio-psycho-social changes with 
major life events in a woman's life with various impacts on health (1, 2). From 
45-60, women's physical and mental health show a marked decline (3-5) and 
long-term sickness, ill health and visits to primary health care (PHC) are more 
frequent than for men (6-10). Midlife often coincides with Menopause 
Transition (MT) which is a hormonal change in a woman's body and a period 
characterized by the ageing of the ovaries with a loss of function, and thus the 
end of fertility in women's lives (11, 12). Researchers have named the period 
as the “Window of vulnerability” (13).  
Women’s health in midlife  
Women, 45-60 show an increased mental, physical, and urogenital illness in 
Sweden and in other OECD countries (1, 2, 14-18). Globally, depressive 
disorders account for close to 42% of mental disorders among women 
compared to 29% among men (19). About 85% of midlife women report at 
least one of the symptoms that usually indicate the presence of depressive 
disorders, vasomotor symptoms, or sleep disorders (15, 20, 21). Common 
mental disorders (CMD) such as depressive, anxiety and stress-related 
illnesses are common causes for women in midlife attending PHC, and risk for 
long-term sick-leave (22). Psychosocial factors have a strong impact on overall 
health, and many life events can influence and impact changes in personal and 
familiar relationships (1, 5, 15). Moreover, the history of impact life stressors, 
lifestyle and cultural traditions varies in the experience of symptoms (1, 16). 
Prevalence of symptoms  
About 60% of women 45 to 60 experience symptoms such as depression 
symptoms, cognitive symptoms, mental exhaustion, sleep problems, 
musculoskeletal pain, dry skin as well as hot flashes, night sweats, vaginal 
dryness, and loss of libido (1, 2, 21, 23-25). However, the prevalence of these 
symptoms vary globally. 
Psycho-social health 
Psycho-social changes of varying degrees occur during midlife. The changes 
often coincide with other changes in personal and social relationships such as 
caring for older parents, teenage children, or major life events such as parental 
death, children leaving home, or becoming grandparents (1, 15). 
Personal attitudes to this period, a history of impacting life events, lifestyle and 
cultural factors will influence how this period of life is experienced (1). 
Psychosocial factors have shown to have a stronger connection to 
psychological symptoms than the stages of menopause (15).  
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Psychosocial factors around midlife show a strong association with 
psychological symptoms, mental health and impacting women’s quality of life 
(5, 15, 16, 26, 27). Factors such as stressful life events, lifestyle, low social 
support, sleep problems, health problems, and relational problems can 
contribute to mental illness (5, 21).  
Stress-related illness 
For midlife women in Sweden severe stress-related illnesses such as 
exhaustion syndrome (ICD-10, F43.8A) and adjustment disorder (ICD-10, 
F43.2) are the most common mental disorders and cause of decreased quality 
of life (4, 9, 28, 29). The length of a stress load and the type of load are 
important to establish a diagnosis. Physical and mental symptoms preceded by 
a long period of stress exposure without adequate recovery and developed for 
at least six months are characterized by lack of mental energy, impaired 
function at work and social contexts. Mental symptoms such as difficulty 
concentrating, memory problems, difficulty coping with demands and time 
pressure, depression, anxiety, irritability, sleep disturbance, marked lack of 
energy and exhaustion are common. Moreover, physical symptoms such as 
pain, cardiovascular palpitations and gastrointestinal problems are also seen. If 
the stress load becomes prolonged, over six months, an adjustment disorder 
can turn into an exhaustion syndrome. Exhaustion syndrome is a consequence 
of prolonged stress without adequate recovery. These symptoms can occur in 
all mental illnesses, but fundamental to stress-related mental illness is a clear 
connection between external events and the patient's symptoms (30). Without 
external events, symptoms would not have occurred. Often the symptoms are 
natural reactions to external stresses. To avoid symptoms becoming long-
lasting and worsening, many patients can be helped by problem-solving and 
short-term support (30).  
Impact on work ability 
Stress-related mental illness has a strong association with long-term sick leave 
for midlife women (9, 28, 29, 31, 32). Exhaustion syndrome (ICD-10, F43.8A) 
and adjustment disorder (ICD-10, F43.2) are the most common causes of long-
term sick leave. Women have a 41 % higher risk to be affected by stress-related 
mental illness than men in Sweden (4, 33). After the age of 50 the risk for 
women being on sick leave increases, and then decreases after 60 (4). 
Adaptation disorders and stress reactions accounts for 66% of the increase in 
started sick leave in Sweden (4). Swedish women have a 25 % higher risk to 
go on sick leave than men, for psychiatric diagnoses the risk is 31 % higher, 
and for stress-related illness a 41% higher risk was seen (4, 33). Of the total 
number of women on sick leave, 31% are women 46-55 (4, 33). Women's share 
of total long-term sick leave over 90 days is 64 % (6). Long-term sick leave 
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increases at a faster rate among women, and the proportion of psychiatric 
illness diagnoses is increasing fastest (34).  
It may be worthwhile to evaluate prognostic factors for health and work ability 
in a population of midlife women over time. 
Health-Related Quality of Life 
Quality of life according to the WHO is "an individual's perception of their 
position in life in the context of the culture and value systems in which they 
live and in relation to their goals, expectations, standards and concerns" (35). 
Quality of life is a subjective and broad concept including indicators of 
physical and mental health, level of education and employment, level of 
independence, access to recreation and leisure time, and social relationships 
(35).  
Previous studies described the concept of health-related quality of life as a 
subjective perception as “the patient’s evaluation of the impact of a health 
condition and its treatment on daily life” and “interferes with a woman’s 
physical, emotional, social and material quality of life”. Considering the 
concept of quality of life, health prevention should take into account the 
perception of the patient regarding severity of symptoms (35-37). Receiving 
social support, work ability, and balance in life are indicators of quality of life 
and associated with a higher quality of life and decreased risk of sick leave (3, 
38-40). Psychosocial factors have a strong connection to quality of life in 
midlife when physiological and psychosocial changes of varying degrees occur 
(1, 15, 41).  
To evaluate the women’s health-related quality of life in midlife, the 
questionnaire Menopause Rating Scale (MRS) is one of the best age- and 
condition-specific health-related quality of life questionnaires (36, 42).  
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Psychosocial factors around midlife show a strong association with 
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increases at a faster rate among women, and the proportion of psychiatric 
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The transition 
Transition is defined as a passage from one state of life to another such like 
puberty, pregnancy, becoming a parent, menopause or retiring (43, 44). A 
transition is an ongoing process and consists of a general structure of the 
changes that occur in three dimensions: entry, passage and exit (45). It can be 
defined as a process with changes in fundamental life patterns at personal and 
family levels, changes in identities, roles, relationships, abilities and patterns 
of behaviour (45, 46). During a transition, stress and anxiety can be 
experienced initially. Successful transition implies greater stability, indicating 
subjective wellbeing, the ability to cope with new roles, healthy relationships, 
and includes increased knowledge and new skills (43, 47). There are several 
factors that may impact the quality and consequences of the  transitions such 
as attitudes, expectations, levels of knowledge, environment, mental and 
physical well-being (45). Therefore, these are important to understand and also 
awareness of the transition process in midlife and how it can impact life.  
The menopause transition 
The menopause transition (MT) is universal and part of a natural ageing 
process in women’s lives including a period of physiological changes. The MT 
can be defined as going from “a reproductive phase to a non-reproductive” 
phase in life (12). Defined as a period of about five years before and five years 
after the last menstruation, it marks the end of a woman's reproductive years 
including hormonal changes as well as bio-psycho-social changes (2, 12, 16, 
17). The transition between 45–60 can impact a woman’s health in different 
ways (17). However, some women pass through this period with few or no 
symptoms, but for many women the transition is a troublesome time of life (23, 
41, 48-50).  
Menopause definition 
Menopause is defined as the last menstruation in a woman´s life and is known 
as the Final Menstrual Period (FMP), marked by the absence of menses for 12 
months without a pathologic cause (2, 11). FMP marks the cessation of the 
menstrual cycle and ovulation, and thus an end of fertility. This entails 
decreased oestrogen levels characterized by ovarian ageing and gradual loss of 
ovarian function (1, 2, 14, 15, 51).  Women in developed countries usually live 
about a third of their lives after menopause.  
The average age of menopause varies between countries from ages 47 to 51 (2, 
23, 51). Mean age for entering menopause in Sweden is 51 (52). Smokers 
commonly enter menopause 2 years earlier than non-smokers.  
Menopause can be divided into natural or induced menopause. The World 
Health Organization (WHO) described the natural menopause as “the 
permanent cessation of menstruation and loss of ovarian function activity”. 
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Induced menopause implies the cessation of menstruation following surgery, 
for example, a hysterectomy or oophorectomy or by chemotherapy or radiation 
(12).  
Menopause can be divided into premature and early menopause. Menopause 
before 45 is termed early menopause and menopause that occurs before 40 is 
termed premature menopause. Premature menopause means that ovarian 
failure occurs by natural or induced causes and affects 1% of women under 40 
(53, 54). 
Menopause transition stages and phases 
To clarify the stages of the menopausal transition and female reproductive 
ageing the WHO and important international menopausal organizations have 
compiled classifications for female reproductive ageing and stages of 
menopause transition (12).  
The Stages of Reproductive Ageing Workshop (STRAW +10) made a 
substantial contribution by means of a standardized seven-stage model 
describing the menopausal phases and reproductive status in healthy women 
(Figure 1) (2). This model STRAW +10, is now a recommended and 
standardized staging system criterion for defining the onset of each stage for 
the natural ageing of women (2). 
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Figure 1. Overview of menopause stage from WHO (12) and STRAW +10 (2). 





The reproductive or premenopausal period, (Stages -5 to -3), comprise regular 
menstrual bleeding within the last 12 months (2, 12). In the late reproductive 
stage (Stage -3), when fertility begins to decline, changes and specifically 
shorter menstrual cycles are noticed (2).  
 
Peri-menopause period 
The perimenopausal or menopausal transition period: (Stages -2 to -1) 
comprise observation of irregular menses within the last 12 months, or the 
absence of menstrual bleeding for more than 3 but less than 12 months. The 
stage is divided by an early and late period. The early menopausal transition 
(Stage -2) is marked by increased changes in menstrual cycle length while the 
late menopausal transition (Stage -1) is indicated by the occurrence of 
amenorrhea of 60 days or longer. Most notable symptoms are vasomotor 
symptoms during this stage -2 to -1. “Peri-menopause” includes the time about 
five years before and after FMP (2). 
 
Post-menopause period  
The post-menopause period: (Stage +1 to +2), marks the end of the 12-month 
period of amenorrhea and is described as having not experienced menstrual 
bleeding for 12 months or more. Early post-menopause (Stage +1) included 
the 12 months after FMP and approximately lasts about 5 to 8 years after the 
FMP. Late post-menopause (Stage +2) continues throughout life. Vasomotor 
symptoms are noticeable during this stage and symptoms of vaginal atrophy 
become more increasingly prevalent (2). 
 
Climacteric  
Climacteric is the period in life of the natural ageing process with hormonal 
changes from a reproductive to non-reproductive stage, and the term is often 
used synonymously with peri-menopause (Figure 1) (12, 36). 
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Common signs and symptoms in midlife 
The most globally prevalent reported symptoms during midlife causing 
reduction of the quality of life were mood changes, depressive symptoms, loss 
of energy, mental exhaustion, muscle and joint problems, dry skin, 
cardiovascular discomfort, sexual problems, sleep disturbances, urinary 
incontinence, and cognitive changes (1, 11, 15, 41, 55-57). These symptoms 
and conditions occurring in the age group 45–60 are not necessarily correlated 
to oestrogen levels and menopause but can be attributed to the menopause 
transition (11, 16). Of the women’s reported symptoms and changes only 
vasomotor dysfunction and vaginal dryness were associated with hormonal 
changes due to decreased oestrogen levels and production (2, 58). Irregular 
bleeding, hot flashes and sweating, as well as symptoms due to dry mucous 
membranes have a clear connection to reduced levels of oestrogen menopause 
(59, 60). Women can experience various signs and symptoms due to decreasing 
oestrogen level protective effect and ageing (11). 
Vasomotor symptoms  
Vasomotor symptoms (VMS) affect about 70% of middle-aged women during 
peri-menopause and strongly impact physical, psychosocial, sleep and quality 
of life (16, 61). VMS remained longer than 7 years for more than half of the 
women and persisted 4.5 years after FMP (61). About 25-30% of women have 
severe symptoms starting well before FMP and continuing far into post-
menopause (16). The symptoms could continue more than 10 years after FMP. 
More than 30 % experience moderate to severe hot flushes and seek treatment 
(36, 61). 
Sleep 
Sleep problems strongly affect quality of life and mental illness. The incidence 
of sleep disorders increased during and after menopause. About 40–60% 
perimenopausal and postmenopausal women reported greater sleep problems 
than premenopausal women. In late peri-menopause symptoms were most 
prevalent regardless of VMS (15). The prevalence of sleep problems greatly 
increases for women in midlife. Commonly reported problems were trouble 
falling asleep, disturbed sleep, and waking up early. Sleep disorders could 
affect duration, regularity, timing, and daytime sleep (16, 62, 63). Studies have 
not shown a direct physiological relationship or link between sleep problems 
and MT (15, 16). Other factors may contribute to poor sleep such as poor health 




Muscle and joint pain 
General stiffness and pain, including musculoskeletal, joint, and body pain, are 
commonly reported by women in menopause transition and increase during 
pre-menopause (65). Muscle and joint discomfort were, in a large mid-aged 
study, the most prevalent and severely rated symptoms, higher rated than 
vasomotor symptoms and appearing early in the pre-menopause (65). Muscle 
and joint discomfort impair quality of life and can persist 5 years beyond 
menopause. Women with depression and sleep problems have a greater risk 
for increased bodily pain (66). 
Cardiovascular health 
For women in midlife, the risk of incidence of cardiovascular disease (CVD) 
increases around menopause (57, 64, 67, 68). The protective effects of 
oestrogens have been suggested as a cause. Oestrogen levels change 
unfavourably for women after menopause with increased Low Density 
Lipoprotein (LDL) and decreased High Density Lipoproteins (HDL) (64, 69, 
70). These changes contribute to a higher risk of CVD. Hypertension is an 
important risk factor for CVD and the onset often affects women in the early 
postmenopausal stage. The years around peri-menopause are accompanied by 
an increase in blood pressure and about 30 to 50% of women develop 
hypertension (>140/90 mmHg) before the age of 60 (71).  Hence, it is 
important to increase women's awareness of cardiovascular risk factors (57, 
68, 72).  
Urogenital symptoms 
Mid-life women with a prevalence of severe urogenital symptoms have a 
strong risk for decreased quality of life and mental illness during and after 
menopause transition (15). 
Urinary incontinence  
Urinary incontinence (UI) is often experienced during and after menopause 
transition (56). UI is defined as unintentional passing of urine when the bladder 
is under pressure, for example on physical exertion or when sneezing or 
coughing, and a sudden, intense urge to urinate followed by an involuntary loss 
of urine. UI is a common health problem especially in midlife women (56, 73). 
Nearly 50% of these women are affected by UI and the severity of leakage was 
shown to be related to a reduction in quality of life with a significant impact 
on women's physical and mental health (73, 74).  
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Vaginal atrophy and local oestrogen deficiency 
symptoms 
Vaginal atrophy increased in MT, in pre- and early peri-menopause from 19% 
to 34% in the post-menopause stage and is a frequent symptom of 
postmenopausal women. Almost 50 % of all postmenopausal women have 
symptoms of local oestrogen deficiency (75). Symptoms of local oestrogen 
deficiency includes vaginal dryness, burning and pain during intercourse, 
itching, frequent urinary tract infections and urinary incontinence (76). It may 
cause sexual problems such as reduced sexual desire. However, changes in 
midlife women’s daily lives, relationships and other above described stressors 
such as long-term stress may reduce sexual desire as well (5, 38, 76, 77). 
Mental health  
Mental health is the basis of our well-being, our health, and our ability to enjoy 
life and our ability to manage and solve life's ups and downs (19, 78, 79). 
Mental health means a life of value and not just the absence of illness or 
discomfort. The concept of mental health includes both good (positive) mental 
health and mental illness (negative) (5, 50). Good mental health is about being 
able to balance positive and negative emotions, to feel well and enjoy good 
social relationships. To master the various difficulties of life, good mental 
health is a basic resource (19, 79). 
The dominating mental health problems for women is mental exhaustion with 
stress-related symptoms described earlier (5, 9, 13), depressive symptoms 
and anxiety. Depressive symptoms and anxiety are more common in late 
peri-menopause and post-menopause than in pre-menopause (1, 5, 13, 25, 
80), also when adjusted for history of depression, poor sleep, and hot flushes 
(13, 80). Women with a history of depression have a 5 times higher risk for 
depression in peri-menopause (15). About 10 to 50 % of peri- and post-
menopausal women reported mood changes (55). The menopausal transition 
is associated with an increased risk for new-onset depression and recurrence 
of previous depressive disorder (5). The risk for depression increases with 
age but a causal link between menopause and depression has not been clearly 
established (5, 13, 15, 17). Previous studies have shown that MHT can 
decrease depression symptoms in perimenopausal period (5, 25, 81, 82).  
More than one in three women suffer from depression symptoms at some point 
in their lives (8, 10), and is a common reason for seeking PHC (6, 8, 9, 83). 
More than 70% of all patients with depression, anxiety or stress-related illness 
are treated in PHC and 20% are referred to a psychiatric specialist (7, 8, 84). 




Management in primary health care   
Primary health care is the basis of health care and is defined by WHO as the 
core of healthcare, playing a key role worldwide with the goal of "better health 
for all" (85).  
PHC is the frontline of care and where the population should first turn with 
their health and medical needs. Focus is on a person's long-term health, 
including medical assessments, treatment and follow-up of diseases not 
requiring hospitalization, and offers preventive measures, health-promoting 
services, and rehabilitation. One of the basic roles of PHC is primary 
prevention measures based on the patient's individual needs (84). To offer the 
patient quality and accessible PHC, defined as "safe, effective, patient-focused, 
knowledge-based, appropriate and equal and accessible" is the goal of PHC 
(84).  
PHC assignment includes care and treatment for CMD and basic psychosocial 
and health-promoting disease prevention interventions, if there is no apparent 
need of hospital care specialists (86). Primary care handles the majority of sick 
leave for mental illness. To deal with mental illness with more than sick leave 
is important for early prevention and health promotion in PHC (33).  
PHC is frontline care providing basic treatment for women with menopausal 
symptoms, and according to guidelines also basic pharmacological treatment 
such as MHT for midlife women(59, 60). It is a PHC responsibility which, 
based on the woman's subjective menopausal symptoms and experience of how 
symptoms affect quality of life, must be decisive when the woman together 
with the caregiver formulates treatment, plans and goals (60, 84).  It is also the 
task of PHC to inform and offer MHT according to guidelines (59, 60) in cases 
of vasomotor menopausal symptoms, and in case of vaginal atrophy offer local 
MHT treatment, as well as offering basic examination and treatment and aids 
for urinary incontinence. 
Another assignment for PHC is disease prevention and health promotion and 
should also offer non-pharmacological treatment such as person-centered 
support, individually or in groups on health-related risk and health factors, 
lifestyle changes independent of disease and health. Health prevention includes 
person-centered conversational support for mapping women's life situations, 
obstacles and resources, stressors, and health factors rimärvården. Midlife 
women may have contact with different caregivers in PHC depending on 
symptoms, were the district nurse’s and midwife’s competencies are important 
in this period of life. If an interdisciplinary intervention, including district 
nurse and midwife competencies in an interdisciplinary procedure with a 
person-centered approach can improve quality of life, needs further study.  
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District nurse 
The district nurse (DN) traditionally has a key role and responsibility for health 
prevention work in PHC (10, 84, 87, 88). She/he works independently and is a 
support for people of all ages and health and medical conditions. The 
psychosocial aspect is an important perspective. DN is often the permanent 
care contact for patients at PHC providing continuity as well as the patient's 
need for coordination and safety (10, 84, 87, 89). 
The district nurse has an independent and central role in public health work, 
where health promotion and disease prevention are aimed at people of all ages, 
both individually, for families, and in groups (87).  The DN works with disease 
prevention through health promotion initiatives and public health work for 
people of all ages, from “the cradle to the grave". The task is focused on 
supporting the healthy and taking advantage of an individual's own resources. 
The importance of health work based on social and socio-cultural contexts and 
influence based on psychosocial conditions are imperatives in the district 
nurse's preventive care and health pedagogical approach (87). Promoting 
health and sound habits through lifestyle changes, as well as with health-
promoting approaches, draws attention to how socio-economic and cultural 
differences affect health. In summary, the district nurse's work is based on a 
health-promoting, person-centered, and health pedagogical approach, with a 
perspective on natural development and ageing (84, 87-89). 
Person-centered care 
Person-centred care (PCC) emanates from theories of person-centredness, an 
ethical ground that guides our actions as professionals. PCC is based on a 
holistic view of the patients as persons with capabilities, responsible for their 
own lives (90-92). PCC in healthcare means building a partnership between 
the patient, her relatives, and the healthcare professionals involving the person 
as an active partner in care and treatment. 
 
PCC contains three key concepts: partnership, patient narrative and 
documentation (93-96).  
 
The concept of partnership is the most central part of PCC. Building the 
partnership involves sharing of information, and shared decision-making, and 
is based on mutual respect for each other's knowledge and expertise. 
Partnership means creating a trusting relationship where the patient feels safe 
and seen as the expert of her condition and its consequences. The starting point 
of the partnership is an invitation to the patient to share her narrative. The 
second concept of patient narrative entails listening to the patient's experience 
of the condition. PCC means seeing and meeting the whole person, not just the 
disease. The focus is on the content of the narrative where the patient's 
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experience, interpretation of their state of health, impact of symptoms on daily 
life, and available resources and opportunities, can contribute to an improved 
life situation. After listening to the patient's narratives, a health plan can be 
jointly constructed with content and strategies to achieve improved health. 
The third component is documentation of the patient narrative in a health-plan, 
which serves at giving legitimacy to patient perspectives and safeguarding the 
partnership. The documentation should be a living document accessible to the 
patient and revised continuously (94, 96, 97).  
 
Patient education 
In primary care different methods of patient education are available to support 
the patient in actively participating in their lifestyle choices and providing 
support to improve quality of life, stimulate self-care and motivate lifestyle 
changes (98, 99). Education can be provided in several forms, two of which 
are group education and person-centred individual support as recommended in 
PHC. 
Participation in group education can be an opportunity to exchange 
experiences and receive information (99, 100). Participants emphasize the 
value of "being with others" and "sharing experiences with others" as important 
factors, emphasizing the value of person-centered support for adaptation 
therapy for patients' different needs for better health and lifestyle changes (99, 
101). Positive effects on knowledge, improved self-management strategies, 
and peer support in group education were shown from a previous overview 
publication (100, 102). The dialogue in group education can raise awareness 
of choices and consequences, create insight into behaviors and provide insight 
into the overall life situation to find the core of ill health (103). Research shows 
that participation in group education can increase opportunity to learn from 
others ’experiences, see their own experiences from a new point of view, gain 
new friends, reduce social isolation, and increase awareness of one's own state 
of health and needs. Moreover, participation increases awareness and insight 
into triggers regarding behavioral patterns and use of medication .  
Research shows that group education for different populations have a health 
economic advantage compared to individual treatment . Most of the studies on 
depression, sleep, hypertension, and diabetes evaluating the effects of patient 
education often had no longer than a six-month follow-up (100, 104-110). 
Previous studies evaluating group education to midlife women with short 
follow-ups of four weeks to six months showed improved quality of life, and 
attitudes and knowledge towards menopausal symptoms (111-116). It may be 
worthwhile to evaluate long-term effects on physical, urogenital, and mental 
health as well as overall quality of life in a population of midlife women in a 
person-centered group education intervention on topics related to menopause 
transition.  
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Person-centred individual support is another method, deeper and more 
personal, where individual needs, narrative and resources are discussed one-
on-one compared with group education. Support is based on needs and 
resources aimed to raise awareness on personal behaviour’s possible effect on 
lifestyle, life events and health, and raising awareness of choices and 
consequences (100). Studies showed faster improved health-related quality of 
life in patients with hypertension, cardiovascular risk, unhealthy lifestyle 
habits or depressive symptoms after receiving person-centred support 
compared to a control group (104, 108, 109, 117).   
There are few studies evaluating individual support and education with a 
follow-up longer than six months (117). Therefore, long-term follow-ups are 
warranted to evaluate long-term effects on physical, urogenital and mental 
health as well as overall quality of life in a population of midlife women in a 





Study I, II, III: The studies were approved by the Regional Ethical Review 
Board in Gothenburg Sweden (registration number 041–09; T503–14) 
Study II was registered in ClinicalTrials.gov with the registration ID: 
NTC02852811. Written informed consent was obtained from all participants 
and confidentiality was ensured. 
Study IV: The study was approved by the Regional Ethical Review Board in 
Gothenburg Sweden (registration number 765-17, 2017-11-16). It was 
registered in ClinicalTrials.gov with the registration ID: NCT03663075. 
Written informed consent was obtained from all participants and 
confidentiality was ensured. 
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AIMS  
General aims  
The overall aim of this thesis was to estimate the prevalence of menopausal 
symptoms and evaluate factors associated with severe symptoms in women 45-
60 in primary care, as well as identify prognostic factors for later unfavourable 
health development and ability to work. The aim was also to evaluate treatment 
methods and clarify which interventions have effects on women's health 
regarding somatic, urogenital, and mental symptoms during the life phase 45-
60 years. In addition, the purpose was to investigate the effect of group 
education or person-centered individual support in primary care on mental 
health, quality of life, care needs and sick leave in women aged 45-60 with 
stress-related symptoms. 
Specific aims 
The specific aims of the included studies in this thesis were: 
 
Study I 
The aim of Study I was to estimate the prevalence of somatic, psychological 
and urogenital symptoms in women aged 45–55 attending PHC and evaluate 
factors associated with severe symptoms. 
 
Study II 
The aim of Study II was to investigate whether group education for women in 
primary health care (PHC) on the menopause transition could improve their 
physical and mental health.  
 
Study III 
The aim of Study III was to investigate prognostic factors for future mental, 
physical, and urogenital health as well as work ability in a population of 
women aged 45–55 years.  
 
Study IV 
The aim of Study IV was to evaluate the effect of group education as well as 
person-centred support in a primary health care context on mental health issues 




PATIENTS AND METHODS 
 
Study designs, selections of participants 
and inclusion criteria (I, II, III, IV) 
This thesis consists of four empiric-atomistic (quantitative) studies. One cross-
sectional study, one longitudinal cohort study and two randomised control trials 
(RCT). The overview is described in Table 1. Studies I, II and III were based on the 
same population, evaluating prevalence (I), group education (II) and prognostic 
factors (III). All patients were recruited from PHC settings in south-western Sweden. 
Women who wanted to participate and fulfilled the inclusion criteria were included.  
 
Table 1. Overview of studies and study populations (I-IV) 
 
 Study I Study II Study III Study IV 
Study design Cross-






control trial  
Study 
population 
n=131 Same study 
population as in 
Study I (n=131) 
Same study 
population as in 
Study I and II 
n= 368 





















A cross-sectional study (I) was followed by a randomised control trial (II) in a 
group intervention followed by a six-year, prospective, longitudinal cohort 
study (III) (Figure 3). The women were consecutively recruited from March 
2009 until December 2010 using recruitment posters when the women, for any 
reason, visited the PHC centers. The inclusion criteria were female gender, 
aged 45 to 55 and no impaired understanding of the Swedish language. The 
exclusions criteria were unwillingness to continue participate in the study and 
new onset of severe mental illness. No limitation was imposed on use of 
prescription drugs.   
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One hundred ten women were assessed. Women were invited to a district nurse 
and midwife at a PHC unit to fill in self-administrated questionnaires and 
demographic data. The self-administered questionnaires assessed the 
prevalence and severity of psychological, urogenital, and somatic symptoms 
and quality of life using the Menopause Rating Scale (MRS), and the severity 
of depressive symptom with the Montgomery-Asberg Depression Rating Scale 
(MADRS-S). The women also reported demographic data regarding age, 
educational level, family, and work status. The women were divided into two 
groups according to menopausal status categorized as still menstruating 
(pre/peri), or not menstruating for more than one year (post), to identify the 
prevalence of somatic, urogenital, and psychological symptoms. Differences 
between the groups were evaluated. A nomogram was constructed for 
predicting the probability of severe menopause symptoms. 
 
Study II 
One hundred ten women were assessed. In this randomised control trial (II), 
all patients were included from the cross-sectional Study I. The inclusion and 
exclusion criteria were the same as in Study I.  Primary outcome effect 
measures were changes in somatic, urogenital, and psychological symptoms 
using (MRS) and depressive symptoms (MADRS). Outcomes were evaluated 
using both intention-to-treat and per-protocol analysis. The outcomes were 
assessed at baseline and were followed up four months later. Effect sizes were 
calculated for the clinical relevance of intervention effects.  
 
Study III  
At the 6-year follow-up (III), all women in Study I were contacted and those 
accepting participation were assessed (n=71). The same study protocol as in 
Study I was used and complemented with information on the women’s health. 
New questionnaires were added such as frequency of sick leave days in the last 
90 days, and health-related quality of life. The Short-Form Health Survey (SF-
36) was used and current medication for hypertension, and cardiovascular 
history was documented. Menopause status was defined according to the 
criteria of the Stages of Reproductive Ageing (STRAW +10), and 
cardiovascular history, including hypertension or previous history of 
myocardial infarction, or cerebrovascular illness were complemented six years 
later.  
 
Study IV  
Three hundred sixty-eight (368) women were assessed. Women were recruited 
by advertising in local papers from November 2018 until May 2019. The 
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inclusion criteria were: some form of mental and/or physical health problems 
such as depression, anxiety, gastrointestinal symptoms, muscular symptoms 
and/or cardiovascular symptoms, sick leave maximum of 30 days during the 
past two months, ability to understand and speak Swedish, no severe illnesses 
such as psychosis, severe depression, or dementia, not in palliative care, and 
no known current alcohol or substance abuse. The exclusion criterion was new 
onset of severe psychological stress or illness. Written informed consent was 
signed, and self-administrated questionnaires were distributed electronically or 
by ordinary mail. The primary outcome effect measures were the Alcohol Use 
Disorders Identification Test (AUDIT), SF-36, the Hospital Anxiety and 
Depression Scale (HADS), the self-rated Exhaustion Disorder Scale (s-ED), 
the Perceived Stress Scale (PSS-14), MADRS and MRS. Other included 
measure were age, educational level, family status and work status, visits to 
PHC and their cause (mental and/or physical), menopause status (bleeding 
pattern and use of hormonal contraception), Menopause Hormone Therapy 
(MHT), alcohol consumption using the Alcohol Use Disorders Identification 
Test (AUDIT), and presence of hypertension. The outcome measures were 
assessed at baseline, and at 6 and 12 months after baseline for comparison 
between groups. 
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Data collection (I, II, III, IV) 
 
Included measurements are listed in Table 2. 
 
Table 2. Overview of measurements used in Study I-IV 








Personal data      
Work ability X X X X 
Sick leave X X X X 
Family status X X X X 
Education level X X X X 
Menopause status X X X X 
Cardiovascular history   X X 
     
Pharamacological treatment     
Menopause Hormone Therapy      X 
Hypertension treatment   X X 
     
Health measures     
The Perceived Stress Scale (PSS-14)    X 
The Exhaustion Disorder Scale (s-ED)     X 
The Hospital Anxiety and Depression Scale (HADS)    X 
The Montgomery–Åsberg Depression Rating Scale (MADRS) X X X X 
The Short-form health survey (SF-36)   X X 
The Menopause Rating Scale (MRS) X X X X 
The Alcohol Use Disorders Identification Test (AUDIT)    X 
 
Personal factors (I, II, III, IV) 
In studies I, II, III and IV, questions on age, education, family and work status, 
care need and contact PHC (only in Study IV), cardiovascular history (only in 
Studies III and IV), menopause status, use of MHT (only in Study IV), 
hormonal contraception (only in Study IV), pharmacological hypertension 
treatment (only in Studies III, IV), alcohol consumption (only in Study IV) and 
health status were registered in a standardized interview. In Study II the history 





Work status (I, II, III, IV) 
Work capacity was categorised by work >1 hour per week or not working. The 
women also registered work/study status, sick leave full-time, sick leave part-
time, disability pension (full-time), disability pension (part-time), unemployed 
full-time or unemployed part-time. Sick leave was registered by number of 
days on sick leave during the preceding 90 days (III).g 
 
Menopause status (I, II, III, IV) 
Menopausal status was used for registering stages of reproductive ageing. The 
criteria of the Stages of Reproductive Ageing Workshop (STRAW +10) were 
used to register menopausal status. The criteria involved the following stages; 
premenopausal - regular menses, perimenopausal women - irregularities >7 
days from their normal cycle, and postmenopausal - no menses in the last 12 
months (2). Questions about use of contraceptives and hormonal contraception 
affecting bleeding patterns was registered as having a hormonal spiral (IUD) 
or other hormonal contraceptive affecting bleeding patterns.  
 
Cardiovascular history (III, IV) 
Cardiovascular status was registered to gain an understanding of the presence 
of the history of cardiovascular illness in midlife women. The presence of 
hypertension was registered as: “never had high blood pressure, or had high 
blood pressure only during previous pregnancy, or think they have previously 
had hypertension unrelated to pregnancy, or currently has high blood pressure 
but unmedicated, or has high blood pressure and is on medication”. The 
presence of cardiovascular history was registered as, “previous history of 
myocardial infarction or cerebrovascular illness”. 
 
Pharmacologic treatment  
Menopause Hormone Treatment (IV) 
Menopause Hormone Treatment (MHT) was registered as: application of MHT 
treatment local, or systemic administration, or not using MHT.  
 
Hypertension treatment (III, IV) 
Hypertension treatment was registered with questions about the presence of 
hypertension and treatment options. 
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Data collection (I, II, III, IV) 
 
Included measurements are listed in Table 2. 
 
Table 2. Overview of measurements used in Study I-IV 
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The Hospital Anxiety and Depression Scale (HADS)    X 
The Montgomery–Åsberg Depression Rating Scale (MADRS) X X X X 
The Short-form health survey (SF-36)   X X 
The Menopause Rating Scale (MRS) X X X X 
The Alcohol Use Disorders Identification Test (AUDIT)    X 
 
Personal factors (I, II, III, IV) 
In studies I, II, III and IV, questions on age, education, family and work status, 
care need and contact PHC (only in Study IV), cardiovascular history (only in 
Studies III and IV), menopause status, use of MHT (only in Study IV), 
hormonal contraception (only in Study IV), pharmacological hypertension 
treatment (only in Studies III, IV), alcohol consumption (only in Study IV) and 
health status were registered in a standardized interview. In Study II the history 
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The Perceived Stress Scale (PSS-14) (IV) 
To assessed general stress, perceived as “unpredictable, uncontrollable, and 
overloading” PSS-14 was used (118). PSS-14 is a self-report questionnaire 
design to register generally perceived stress and to assess “the degree to which 
situations in one’s life are appraised as stressful” and perceived as 
“unpredictable, uncontrollable, and overloading” and to identify risk for 
depression (118). The PSS-14 comprises 14 items with a five-point scale (0 to 
4), where higher scores indicate a higher level of perceived stress symptoms. 
The questionnaire has good reliability and validity (118).  
 
Exhaustion Disorder Scale (s-ED) (IV)  
The self-rated s-ED was used to identify risk of developing exhaustion 
syndrome and risk of sick leave absence (119). The s-ED was developed in 
Sweden, based on the diagnostic criteria for exhaustion syndrome (ICD 10, 
code F43.8) regarding perceived stress and stress-related ill health. The form 
comprises four items with sub-items. Higher scores indicate a higher level of 
symptoms and risk of developing a clinical exhaustion syndrome. The 
questionnaire has good reliability and validity (119).  
 
The Montgomery–Åsberg Depression Rating Scale (MADRS)  
(I, II, III, IV) 
The MADRS is a validated questionnaire and was used to register the severity 
of depression symptom. This questionnaire was developed in the late 70s by 
British and Swedish researchers (120, 121). The MADRS consists of nine 
items, each scored from 0 to 6, with a maximum score of 54, where higher 
scores indicate more severe symptoms. The nine items are, 1) Apparent 
Sadness 2) Inner Tension 3) Reduced Sleep 4) Reduced Appetite 5) 
Concentration Difficulties 6) Lassitude 7) Inability to Feel 8) Pessimistic 
Thoughts and 9) Suicidal Thoughts. The total MADRS-S score was calculated 
according to the manual (English version). Foreign standards were interpreted 
as follows; 0-6 points essentially effortless, 7-19 points mild depression, 20-
34 points moderate depression, > 34 points severe depression (121). The total 
MADRS-S score was calculated according to Swedish standards interpreted as 
follows; 0-12 points essentially effortless, 13-19 points mild depression, 20-34 





The Hospital Anxiety and Depression Scale (HADS) (IV) 
To examine anxiety and depressive symptoms, HADS was used (123). The 
HADS consists of 14 items, seven items for anxiety (HADS-A) and seven for 
depression (HADS-D) graded on a 4-point scale (0 and 3 points) where higher 
scores indicate a higher level of symptoms. The cut-off score of 8 is suggested 
to indicate possible clinical anxiety and depression (124). The questionnaire 
has good reliability and validity (124).  
 
The Short-Form health survey (SF-36) (III, IV) 
For health-related quality of life, SF-36 was used (125). The SF-36 consists of 
eight sub-scales: Physical Functioning (PF), Role-Physical (RF), Bodily Pain 
(BP), Mental Health (MH), Role-Emotional (RE), Vitality (VT), General 
Health (GH) and Social Functioning (SF). Scores for the sub-scales are 
between 0-100, a higher value indicates better perceived health. Two summary 
scores present an overall health index of mental and physical health (range 0–
100): the Physical Component Summary (PCS) including PF, RP, BP, GG and 
the Mental Component Summary (MCS) including VT, SF, RE, MT. A higher 
value indicates better perceived health. The Swedish version of the 
questionnaire shows reliability and validity (125). 
 
The Menopause Rating Scale (MRS) (I, II, III, IV) 
The MRS was used to evaluate the prevalence and severity of menopausal 
symptoms and assess health-related quality of life in ageing women. The 
instrument is a self-administrated questionnaire developed in the early 1990s 
by Heinemann and validated in Sweden and has been translated into 25 
languages (126). MRS consists of eleven items, categorised into three sub-
scales reflecting; somatic symptoms - hot flushes, chest discomfort (irregular 
heart rhythm or feeling extra heartbeats), sleeping problems and muscle and 
joint problems; psychological symptoms - depressive mood, irritability, 
anxiety, and physical and mental exhaustion; and urogenital symptoms - sexual 
problems, bladder problems and vaginal dryness. Item ranged from 0 (not 
present) to 4 (1=mild; 2= moderate; 3=severe; 4=very severe). The MRS total 
score is the sum of obtained scores for each sub-scale. Severe menopausal 
symptoms were defined as values equal to or above 9 (somatic), 7 
(psychological), 4 (urogenital), and 17 (total) (127, 128).  
 
The Alcohol Use Disorders Identification Test (AUDIT) (IV) 
The AUDIT was used to identify alcohol consumption, drinking behavior and 
risk habit (129). The AUDIT is self-administrated containing ten items 
categorized into three domains: consumption, addiction, and alcohol-related 
harm. Scores above the cut-off limit of 6 points for women indicate risky 
drinking habits (129).   
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The Alcohol Use Disorders Identification Test (AUDIT) (IV) 
The AUDIT was used to identify alcohol consumption, drinking behavior and 
risk habit (129). The AUDIT is self-administrated containing ten items 
categorized into three domains: consumption, addiction, and alcohol-related 
harm. Scores above the cut-off limit of 6 points for women indicate risky 
drinking habits (129).   
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Randomization procedure (Studies II, IV) 
In Study II, the women were allocated by randomization to group education or 
a control group. Sealed opaque envelopes were created by a random allocation 
sequence. Participants and investigators were not blinded to group allocation. 
All women were invited to a baseline consultation after randomization.  
In Study IV, the women were randomized using block-randomization in blocks 
of four. This randomization sequence was transferred to sequentially numbered 
closed sealed opaque envelopes. A note inside allocated the women to Group 
1: Group Education (GE), group 2: GE and Person-Centered individual support 
(PCS), group 3: PCS and group 4: Control Group. Participants and 
investigators were not blinded to group allocation. 
 
Interventions (II, IV) 
The educational program in Studies II and IV, The Menopause Transition 
Education (MTE) was designed and developed by a district nurse and a 
midwife based on MRS subjects. The content of the educational program is 
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Table 3. Overview of topics in the person-centered interventions the Menopause Transition Education.  




1 Definition of menopause transition, myths, 
epidemiology, physiology, bleeding disorders, hot 
flushes and sweating, local estrogen deficiency 
symptoms, incontinence, vaginal atrophy, osteoporosis 
 X  X  
2  Cardiovascular health, - physiology, - risk and health 
factors, sleep, stress related illness, mental illness, social 
relationships, sexuality and desire 
X  X  
3  Specialization in the subjects of stress-related illness, 
depression, mental health, sleep and social relationships 
 X  
4  Specialization in the subjects of stress-related and mental 
illness, social relationships, sexuality and desire. Recap 
and summary. 
 X  
5  Last Individual session, contained a recap and summary    X  
 
The educational program Study II 
The group intervention consisted of two one-and-one half hour weekly 
sessions and took place within PHC. The second session took place the 
following week (Figure 2). Each group included 8–10 women and was 
supervised by a district nurse and midwife and consisted of sessions about 
topics related to menopause. Topics were related to physical, urogenital, 
mental, and psycho-social changes related to menopause as well as 
conversations aimed to clarify consequences of behavior, choices in life, and 
to stimulate desired behavioural changes. 
 
The education, The Menopause Transition Education (MTE) was performed 
by a district nurse and a midwife based on MRS subjects. The educational 
program topics were: Session 1: A definition of menopause, general facts and 
myths about menopause, the menstrual cycle, menopause transition, local 
oestrogen deficiency symptoms including urogenital symptoms, osteoporosis 
and information about prevention, health promotion self-care and time for 
discussion and questions. Session 2 focused on cardiovascular risk and healthy 
factors during menopause, depressive symptoms, mental unhealth, stress, 
sleep, relationship, sexual health, and desire, as well as information on 
prevention and health promotional lifestyle factors to improve health. Time 





The control group 
In Study II, the control group (CG) received the same education as the IG group 
four months later. 
 
The educational program Study IV 
The educational program focused on a person-centered approach in both group 
education and individualized treatment and were performed by a district nurse 
and midwife. The interventions contained information and discussions about 
biological processes as well as psychological and psychosocial aspects of 
menopause. Menopause transition as a natural part of life was emphasized and 
specific treatment options according to the guidelines were clarified. The 
topics were based on the MTE program from Study II, with greater focus on 
some subjects (Table 3).  Prevention and health promotional lifestyle factors 
to improve health were discussed as well as lifestyle modifications to improve 
health. 
 
Group education sessions (IV) 
Group education comprised four one-and-one half hour weekly sessions 
including 12 to 16 women in the group sessions (Figure 2). The sessions were 
based on topics related to mental, urogenital, and physical changes as well as 
changes in psycho-social events aimed to impact lifestyle modifications to 
improve health (Table 3). 
 
Person-centered individual sessions (IV) 
Person-centered individual therapy comprised five, one hour, individually 
structured person-centered sessions, and were performed by a district nurse or 
midwife (Figure 2). The sessions were personal focusing on the participant’s 
individual situation based on the woman´s narratives, needs, resources and 
beliefs. The topics were the same as in group education. (Table 3). 
 
Control group 
The control group received no intervention and were informed to seek advice 
wherever they wished outside the range of the study. 
  




Table 3. Overview of topics in the person-centered interventions the Menopause Transition Education.  




1 Definition of menopause transition, myths, 
epidemiology, physiology, bleeding disorders, hot 
flushes and sweating, local estrogen deficiency 
symptoms, incontinence, vaginal atrophy, osteoporosis 
 X  X  
2  Cardiovascular health, - physiology, - risk and health 
factors, sleep, stress related illness, mental illness, social 
relationships, sexuality and desire 
X  X  
3  Specialization in the subjects of stress-related illness, 
depression, mental health, sleep and social relationships 
 X  
4  Specialization in the subjects of stress-related and mental 
illness, social relationships, sexuality and desire. Recap 
and summary. 
 X  
5  Last Individual session, contained a recap and summary    X  
 
The educational program Study II 
The group intervention consisted of two one-and-one half hour weekly 
sessions and took place within PHC. The second session took place the 
following week (Figure 2). Each group included 8–10 women and was 
supervised by a district nurse and midwife and consisted of sessions about 
topics related to menopause. Topics were related to physical, urogenital, 
mental, and psycho-social changes related to menopause as well as 
conversations aimed to clarify consequences of behavior, choices in life, and 
to stimulate desired behavioural changes. 
 
The education, The Menopause Transition Education (MTE) was performed 
by a district nurse and a midwife based on MRS subjects. The educational 
program topics were: Session 1: A definition of menopause, general facts and 
myths about menopause, the menstrual cycle, menopause transition, local 
oestrogen deficiency symptoms including urogenital symptoms, osteoporosis 
and information about prevention, health promotion self-care and time for 
discussion and questions. Session 2 focused on cardiovascular risk and healthy 
factors during menopause, depressive symptoms, mental unhealth, stress, 
sleep, relationship, sexual health, and desire, as well as information on 
prevention and health promotional lifestyle factors to improve health. Time 





The control group 
In Study II, the control group (CG) received the same education as the IG group 
four months later. 
 
The educational program Study IV 
The educational program focused on a person-centered approach in both group 
education and individualized treatment and were performed by a district nurse 
and midwife. The interventions contained information and discussions about 
biological processes as well as psychological and psychosocial aspects of 
menopause. Menopause transition as a natural part of life was emphasized and 
specific treatment options according to the guidelines were clarified. The 
topics were based on the MTE program from Study II, with greater focus on 
some subjects (Table 3).  Prevention and health promotional lifestyle factors 
to improve health were discussed as well as lifestyle modifications to improve 
health. 
 
Group education sessions (IV) 
Group education comprised four one-and-one half hour weekly sessions 
including 12 to 16 women in the group sessions (Figure 2). The sessions were 
based on topics related to mental, urogenital, and physical changes as well as 
changes in psycho-social events aimed to impact lifestyle modifications to 
improve health (Table 3). 
 
Person-centered individual sessions (IV) 
Person-centered individual therapy comprised five, one hour, individually 
structured person-centered sessions, and were performed by a district nurse or 
midwife (Figure 2). The sessions were personal focusing on the participant’s 
individual situation based on the woman´s narratives, needs, resources and 
beliefs. The topics were the same as in group education. (Table 3). 
 
Control group 
The control group received no intervention and were informed to seek advice 
wherever they wished outside the range of the study. 
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Statistical analysis (I, II, III, IV) 
In all studies, (I, II, III, IV) the level of significance was p < 0.05. In Table 4, 
statistical tests are presented. The Statistical Package Software for Social 
Sciences (SPSS), Windows version 19.0, 22.0, 25.0 and 27.0 was used for 
statistical analyses in all study (I, II, II, IV). Analysis was by intention-to-treat 
and per-protocol in Study II and IV. Analysis complete case was also analysed 
in Study IV. 
 
Table 4. Overview of statistical test included in the thesis. 
 
Descriptive data (I, II, III, IV) 
Group characteristics are presented with mean and standard deviations (SD), 
median and 25th and 75th percentile, median and interquartile range (IQ), or 
the number and percentage (%) were used. 
 
Between group comparison (II, IV) 
Changes between groups in baseline and follow-ups were calculated (Study 
II). Raw changes were transformed to improvement (coded as +1), worsening 
(coded as −1) or no change (coded as 0). For between group comparison the 
Student’s t-test for unmatched groups and the Mann-Whitney U test was used 
for the raw changes. The Mann-Whitney U–test was also used for transformed 
changes (Study II). In Study IV, changes between baseline and follow-ups 
were calculated. Changes between baseline and follow-ups for nominal data 
are presented as a number (%) and changes in questionnaires are presented as 
the mean change Standard deviation (SD). Changes were also categorised into 
three categories: worsening, unchanged or improved (coded as -1, 0, +1) 
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Chi square test 
with Yates’s correction  
 X   
Fisher’s exact test  X   
Mann Whithey U test  X   
Student’s T-test  X   
Spearman correlation  X   X   
Multivariable linear regression      X  
Multivariable logistic regression X   X  X  




Prevalence of severe menopausal symptoms (I) 
Estimates of the prevalence of somatic, urogenital, and psychological 
symptoms and depressive symptoms were described as numbers and 
proportions (Study I). 
 
Logistic regression factors associated with severe 
menopausal symptoms (I) 
To estimate the assessment factors associated with severe symptoms a binary 
logistic regression was made for each dichotomized MRS score. The mean 
value for the dichotomized MRS score was somatic symptoms ≥9=1/≤ 8 = 0, 
urogenital symptoms≥4=1/≤ 3 = 0, psychological symptoms ≥7=1/≤ 6=0 and 
total score ≥ 17 = 1/≤ 16 = 0. Independent explanatory variables in the 
regression were: age 45–55, work status; living with a partner, educational 
level, depressive symptoms score (MADRS ≥7 = 1/< 6 = 0). First, several 
unadjusted logistic regressions were performed to assess the associations 
between each of the independent and dependent variables of severe somatic, 
urogenital, psychological, and total symptoms in MRS. For zero order 
correlations significant variables were evaluated. Secondly, a forward stepwise 
multivariate (adjusted) logistic regression was made including the independent 
variables with a significant association to severe symptoms in MRS. To 
validate any multivariate logistic regression models the area under a curve 
(AUC) was performed (Study I). Lastly, to predict the probability of severe 
menopausal symptoms a multivariabel logistic model was transformed into a 
probability nomogram (Study I). 
 
Nomogram (I)   
To read the nomogram: 1) identify whether the patient has severe menopausal 
symptoms or no severe menopausal symptoms (MRS) >17, 2) affirm the 
patient’s age and follow the corresponding line, 3) locate the depression score 
(MADRS) >7 and draw a horizontal line straight to the probability of severe 
menopausal symptoms axel and find the patient´s probability of severe 
menopausal symptoms (Study I). 
 
Prognostic factors (III) 
For all eight sub-scales of SF-36 a cut-off was introduced at the mean value 
for Swedish women aged 46–54 (125, 130). Being equal to or higher than the 
mean was coded as 1, and being lower coded as 0. Logistic regressions were 
used to identify prognostic factors. First, several multivariable logistic 
regressions were made to identify prognostic factors, one for each of the 
following dependent variables estimated at the 6-year follow-up: work ability, 
presence of hypertension and the dichotomization of the eight sub-scales in 
SF-36. The independent variables with a statistically significant association 
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Statistical analysis (I, II, III, IV) 
In all studies, (I, II, III, IV) the level of significance was p < 0.05. In Table 4, 
statistical tests are presented. The Statistical Package Software for Social 
Sciences (SPSS), Windows version 19.0, 22.0, 25.0 and 27.0 was used for 
statistical analyses in all study (I, II, II, IV). Analysis was by intention-to-treat 
and per-protocol in Study II and IV. Analysis complete case was also analysed 
in Study IV. 
 
Table 4. Overview of statistical test included in the thesis. 
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with each of the dependent variables after six years were included in a stepwise 
multivariable logistic regression. Before logistic regression, multicollinearity 
was evaluated by the value of tolerance and variance inflator factor (VIF) 
between independent variables. Independent explanatory variables from the 
baseline measurement in the logistic regression were: age, working, living with 
a partner, having children living at home, education, work ability, any 
depression measured with MADRS ≥7, MRS somatic symptoms ≥9, MRS 
urogenital symptoms ≥4, MRS mental symptoms ≥7 and MRS total score ≥ 17, 
received active intervention (to adjust for any intervention given in the 
previous RCT) (Study III). 
 
Two-factor analysis (IV)/ 
A two-factor design with four parallel arms was used and inferential statistical 
analysis was repeated for intention to treat (ITT), complete case (CC) and per 
protocol (PP) analysis (IV). Linear and ordinal regression were used for the 
effect of either intervention follow-ups (Table Supplemental 1, 2, 3, 4, study 
IV). Linear regression was first performed with mean change in SF-36, HADS, 
s-ED, PSS-14, MADR-S and MRS as the dependent variable. The dependent 
variables were transformed with Blom’s rank-based method (131) when mean 
changes were not normally distributed (Table Supplemental 1 and 3, study IV). 
Independent variables were group education (GE), person-centered individual 
support (PCS), and the interaction between GE and PCS. All analyses were 
adjusted for age. The Beta coefficient in the linear regressions provides 
information about direction of effect and should not be interpreted as ranked 
data (Supplement Tables 1 and 3, Study IV). Multicollinearity were checked 
for assumptions for linear regression (Supplemental Tables 1 and 3, study IV). 
Next, ordinal regressions were performed. Changes in outcome variables were 
transformed coded as improvement +1, worsening -1 and unchanged as 0, and 
was used as the dependent variable. Independent variables were group 
education (GE), person-centered individual support (PCS) and interaction 
between GE and PCS. All analyses were adjusted for age regression 
(Supplemental Tables 2 and 4, Study IV). 
 
Finally, in a summary table the results from linear and ordinal regressions were 
presented with statistically significant effects of any of the two interventions 
denoted with a + sign in at least one of ITT, CC and PP. A double + sign 
indicates a desired effect of intervention seen in two of the three statistical 
analyes and three + signs indicate a statistically significant effect in all three 
analyses. In analogue with this 1-3 minus signs indicate a statistically 
significantly undesired effect of the intervention. In the ordinal regression of 
the ITT analysis the odds ratio was also presented for any statistically 




symptoms. Desired effect in some outcome variables result in an odds ratio >1 
while in others an odds ratio <1. To clarify, a desired effect always had an odds 
ratio >1 while an undesired effect always had an odds ratio <1, and was 
transformed in the summary table (Table 3, Study IV).  
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The present thesis will be available digitally. To avoid problems with 
publication of the results for Study IV these results are only presented briefly. 
The result tables for Study IV are presented in detail in the attached manuscript 
in the printed thesis. Therefore, Study IV with table numberings are according 








































Figure 3. Participant flow Study I, II and III 
  
Assessed for eligibility (n = 142) 
Randomized (n=131) 
First assessment (n=110) 
STUDY I and STUDY II 
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reached n=11 
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Did not state reason n=22 
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Result Study I  
One hundred and ten women age 45-55 were assessed (Figure 3) and the 
characteristics for total group and pre/peri- and postmenopausal group are 
shown in Table 5. The mean values for age were 50 (SD 3.0) for the total group 
for the group pre/peri 50 (SD 3.1), for the post group 52 (SD 3.0) (p=0.0049). 
Information about menopausal stage for menstruation was missing for 15% of 
the women due to contraceptive treatments with hormones, hysterectomy or 
not having provided a clear statement on menstruation (Table 5).  
The post-menopausal group showed statistically significant more severe 
somatic symptoms (hot flushes, coronary discomfort, sleeping problems and 
muscle and joint problems) measured with MRS compared to the pre/peri-
pausal group (p=0.033). Mean values for somatic symptoms (MRS) were 4.2 
(SD 2.9) for the total group, the group pre/peri 3.9 (2.9) and for the post-
menopausal group 5.1 (2.5) (p=0.033). No differences between groups were 
found for the psychological and urogenital symptoms in MRS or in depressive 






Table 5. Demography, depression, and symptom scores among women 45-55 years 




(n=25)  P-value 
 Age (y)c 50 (3)  50 (3.1)  52 (3.0)  0.0049 
        
Education (y)d          
 Primary school (<9) 20 (18)                              8  (12)   7  (28)                  
 Secondary school (10-12) 51 (46)  31 (45)  11(44)   0.0065 
 Tertiary school (>12) 39 (36)  30 (44)  7 (28)   
        
Workd        
In work  92 (84)  57 (83)  21 (84)  0.87 
        
Family statusd        
Living with a partner 98 (89)  61 (88)  23 (92)  0.62 
        
MRS scoree        
 Somaticf 4.2 (2.9) 4.0 (2-6) 3.9 (2.9) 3.0 (2-6) 5.1 (2.5) 5.0 (4-7) 0.033 
 Urogenitalf 2.5 (2.4) 2.0 (1-4) 2.2 (2.3) 2.0 (0-4) 3.2 (2.3) 2.0 (2–5) 0.091 
 Psychologcalf 3.8 (3.0) 3.0 (1-6) 3.9 (3.1) 3.0 (1-6) 3.8 (2.8) 4.0 (2-6) 0.90 
 Totalf 10 (6.4) 9.5 (5-15) 9.8 (6.6) 8 (4-15) 12 (5.6) 11 (10-5) 0.068 
        
Depression scored,g        
No 58 (53)  36 (52)  12 (48)   
 Mild 45 (41)  29 (42)  11 (44)   
 Moderate 7 (6.4)  4 (58)  2 (8)  0.54 
 Major 0 (0.0)  0 (0.0)  0 (0.0)   
 Sumscore h 8.2 (5.9)  6.0 (4-12) 8.6 (6.0) 6 (4-13) 7.6 (5.6) 7 (4-11) 0.58 
a Still menstruation 
b No menstruation since more than one year ago 
c First figure mean values (SD). 
d n (%) 
e Subscale and total Menopause Rating Scale (MRS) scoring. The reference values for the symptoms are follow: > 8 (somatic), > 6 
(psychological), > 3 (urogenital) and >16 (total MRS) was defined as severe. First figure mean (SD) second figure median (25th and 
75th percentile).  Degree of severity  of the MRS and its domains indicated; Total score;  No, little (0–4), Mild (5–8), Moderate (9–16), 
Severe (17+), Psychological domain; No, little (0–1), Mild (2–3), Moderate (4–6),Severe (7+), Somatic  domain;  No, little (0–2), Mild 
(3–4);Moderate (5–8), Severe (9+), Urogenital domain; No, little (0), Mild (1), Moderate (2–3),Severe (4+).    
f n 65          
g Montgomery-Asberg Depression Rating Scale (MADRS) scoring.  
h First figure n (%) First figure mean (SD) second figure median (25th and 75th percentile). International standards; 0-6 p no 
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For the total group MRS somatic score indicated mild symptoms, for 
urogenital and psychological score moderate symptoms (Tables 6). The five 
most frequently reported MRS symptoms were; physical and mental 
exhaustion (73 %), depressive mood (66 %), sleep problems (66 %), hot 
flushes (66 %), muscle and joint problems and sexual problems (62 %). The 
five most “severe to very severe” MRS symptoms were; sleeping problems (18 
%), depressive mood (18 %), muscle and joint problems (12 %), physical and 
mental exhaustion (10 %) and sexual problems (9 %) compared with hot 
flushes (5 %) as were ranked ninth of eleven in the present series. In Table 6 
the prevalence of menopause symptoms registered in MRS sub-scales are 
presented.  





The Hospital Anxiety and Depression Scale (HADS) (IV) 
To examine anxiety and depressive symptoms, HADS was used (123). The 
HADS consists of 14 items, seven items for anxiety (HADS-A) and seven for 
depression (HADS-D) graded on a 4-point scale (0 and 3 points) where higher 
scores indicate a higher level of symptoms. The cut-off score of 8 is suggested 
to indicate possible clinical anxiety and depression (124). The questionnaire 
has good reliability and validity (124).  
 
The Short-Form health survey (SF-36) (III, IV) 
For health-related quality of life, SF-36 was used (125). The SF-36 consists of 
eight sub-scales: Physical Functioning (PF), Role-Physical (RF), Bodily Pain 
(BP), Mental Health (MH), Role-Emotional (RE), Vitality (VT), General 
Health (GH) and Social Functioning (SF). Scores for the sub-scales are 
between 0-100, a higher value indicates better perceived health. Two summary 
scores present an overall health index of mental and physical health (range 0–
100): the Physical Component Summary (PCS) including PF, RP, BP, GG and 
the Mental Component Summary (MCS) including VT, SF, RE, MT. A higher 
value indicates better perceived health. The Swedish version of the 
questionnaire shows reliability and validity (125). 
 
The Menopause Rating Scale (MRS) (I, II, III, IV) 
The MRS was used to evaluate the prevalence and severity of menopausal 
symptoms and assess health-related quality of life in ageing women. The 
instrument is a self-administrated questionnaire developed in the early 1990s 
by Heinemann and validated in Sweden and has been translated into 25 
languages (126). MRS consists of eleven items, categorised into three sub-
scales reflecting; somatic symptoms - hot flushes, chest discomfort (irregular 
heart rhythm or feeling extra heartbeats), sleeping problems and muscle and 
joint problems; psychological symptoms - depressive mood, irritability, 
anxiety, and physical and mental exhaustion; and urogenital symptoms - sexual 
problems, bladder problems and vaginal dryness. Item ranged from 0 (not 
present) to 4 (1=mild; 2= moderate; 3=severe; 4=very severe). The MRS total 
score is the sum of obtained scores for each sub-scale. Severe menopausal 
symptoms were defined as values equal to or above 9 (somatic), 7 
(psychological), 4 (urogenital), and 17 (total) (127, 128).  
 
The Alcohol Use Disorders Identification Test (AUDIT) (IV) 
The AUDIT was used to identify alcohol consumption, drinking behavior and 
risk habit (129). The AUDIT is self-administrated containing ten items 
categorized into three domains: consumption, addiction, and alcohol-related 
harm. Scores above the cut-off limit of 6 points for women indicate risky 
drinking habits (129).   
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 Hot flushes, sweating: 34 (37/109)                                                                   32 (35/109) 29 (32/109) 4.0 (4/109) 1.0 (1/109) 
 Heart discomfort: 52 (56/108) 28 (30/108) 19 (21/108) - 1.0 (1/108) 
 Sleeping problems:  33 (36/108) 26 (28/108) 24 (26/108) 13 (14/108) 5.0 (5/108) 
 Muscle and joint problems:    38 (42/108) 21(2 /108) 28 (31/108) 10 (11/108) 2.0 (2/108) 
Psychologicala 
 Depressive mood: 33 (36/108) 26 (28/108) 24 (26/108) 13 (14/108) 5.0 (5/108) 
 Irritability: 41 (44/108) 37 (40/108) 17 (18/108) 6.0 (6/108) - 
 Anxiety: 47 (51/108) 33 (36/108) 16 (17/108) 4.0 (4/108) - 
 Physical and mental exhaustion: 27 (29/109) 44 (48/109) 19 (21/109) 8.0 (9/109) 2.0 (2/109) 
Urogenitala 
 Sexual problems: 38 (42/109) 33 (36/109) 20 (22/109) 5.0 (5/109) 4.0 (4/109) 
 Bladder problems: 50 (53/108) 34 (37/108) 12 (13/108) 3.0 (3/108) 2.0 (2/108) 
 Dryness of vagina: 53 (57/108) 28 (30/108) 12 (13/108) 5.0 (5/108) 3.0 (3/108) 





The Hospital Anxiety and Depression Scale (HADS) (IV) 
To examine anxiety and depressive symptoms, HADS was used (123). The 
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scores indicate a higher level of symptoms. The cut-off score of 8 is suggested 
to indicate possible clinical anxiety and depression (124). The questionnaire 
has good reliability and validity (124).  
 
The Short-Form health survey (SF-36) (III, IV) 
For health-related quality of life, SF-36 was used (125). The SF-36 consists of 
eight sub-scales: Physical Functioning (PF), Role-Physical (RF), Bodily Pain 
(BP), Mental Health (MH), Role-Emotional (RE), Vitality (VT), General 
Health (GH) and Social Functioning (SF). Scores for the sub-scales are 
between 0-100, a higher value indicates better perceived health. Two summary 
scores present an overall health index of mental and physical health (range 0–
100): the Physical Component Summary (PCS) including PF, RP, BP, GG and 
the Mental Component Summary (MCS) including VT, SF, RE, MT. A higher 
value indicates better erceived health. The Swedish version of the 
questionnaire shows reliability and validity (125). 
 
The Menopause Rating Scale (MRS) (I, II, III, IV) 
The MRS was used to evaluate the prevalence and severity of menopausal 
symptoms and assess health-related quality of life in ageing women. The 
instrument is a self-administrated questionnaire developed in the early 1990s 
by Heinemann and validated in Sweden and has been translated into 25 
languages (126). MRS consists of eleven items, categorised into three sub-
scales reflecting; somatic symptoms - hot flushes, chest discomfort (irregular 
heart rhythm or feeling extra heartbeats), sleeping problems and muscle and 
joint problems; psychological symptoms - depressive mood, irritability, 
anxiety, and physical and mental exhaustion; and urogenital symptoms - sexual 
problems, bladder problems and vaginal dryness. Item ranged from 0 (not 
present) to 4 (1=mild; 2= moderate; 3=severe; 4=very severe). The MRS total 
score is the sum of obtained scores for each sub-scale. Severe menopausal 
symptoms were defined as value  equal to or bove 9 (somatic), 7 
(psychological), 4 (urogenital), and 17 (total) (127, 128).  
 
The Alcohol Use Disorders Identification Test (AUDIT) (IV) 
The AUDIT was used to identify alcohol consumption, drinking behavior and 
risk habit (129). The AUDIT is self-administrated containing ten items 
categorized into three domains: consumption, addiction, and alcohol-related 
harm. Scores above the cut-off limit of 6 points for women indicate risky 
drinking habits (129).   
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Factors associated with menopausal symptoms as 
measured with MRS. 
More severe depression symptoms (MADRS) and increasing age were 
associated with more severe menopausal symptoms (MRS) (Table 7). Adjusted 
model accounted for approximately 39 % of the variance of menopausal 
symptoms (Nagelkerke R2) with area under curve (AUC) of 0.86 (CI 0.78-
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Table 7. Factors associated with menopausal symptoms as measured with Menopause Rating Scale (MRS) (n=109). 
 Menopausal symptoms 





Total of symptoms 
>16 
 OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value 
Unadjusted        
Agea 1.1 (0.87-1.4) 0.46 1.2 (1.0-1.4) 0.014 1.1 (0.96-1.3) 0.15 1.2 (1.01-1.4) 0.037 
Living with partner 1.0 (0.11-8.8) 1.0 1.8 (0.36-8.6) 0.48 1.3 (0.27-6.5) 0.74 4.3 x 108 (0.0-∞) 1.0 
Workingb 0.11 (0.026-0.47) 0.0028 0.55 (0.18-1.7) 0.29 0.21 (0.067-0 62) 0.0051 0.24(0.077-0.74) 0.013 
Tertiary educationc 0.50 (0.99-2.5) 0.40 0.44 (0.16-1.2) 0.11 0.83 (0.31-2.2) 0.71 0.75(0.26-2.1) 0.59 
Depressiond 3.4x108 (0.0-∞) 1.0 2.2 (0.91-5.5) 0.079 10 (2.8-37) 0.00044 31.6 (4.2-247) 0.00099 
Menopausee 0.42 (0.48-3.7)  0.44 1.3(0.50-3.8) 0.53 0.61 (0.18-2.03) 0.42 1.1 (0.36-3.7) 0.82 
Adjusted        
Agea       1.2 (1.0-1.5) 0.041 
Depressiond     10 (2.8-37) 0.00044 33 (4.2-270) 0.00091 
a Odds Ratio for an increase in age of one year between 45-55 years 
b Working more than one hour/week 
c Primary school/ secondary school vv tertiary school 
d Montgomery-Asberg Depression Rating Scale (MADRS) score ≥ 7 
e Menopause one year after last menstruation 
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The Hospital Anxiety and Depression Scale (HADS) (IV) 
To examine anxiety and depressive symptoms, HADS was used (123). The 
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Figure 4. Study II Nomogram, the probability of severe menopausal symptoms among 
women. Depression = MADRS ≥7 (mild or moderate or severe depression). Severe 





Result Study II 
 
One hundred and ten women were randomised to either the intervention group 
(IG) (n=55) or control group CG (n=55) (Figure 3). No significant baseline 
differences were found (Table 8).  
In both groups, somatic symptoms (MRS) indicated mild urogenital symptoms 
(MRS) and psychological symptoms (MRS) and for total score moderate 
symptoms (MRS) at baseline (Table 8). Depressive symptoms (MADRS) 
indicated mild depression in both groups at baseline (Table 8). 
  





Figure 4. Study II Nomogram, the probability of severe menopausal symptoms among 
women. Depression = MADRS ≥7 (mild or moderate or severe depression). Severe 





Result Study II 
 
One hundred and ten women were randomised to either the intervention group 
(IG) (n=55) or control group CG (n=55) (Figure 3). No significant baseline 
differences were found (Table 8).  
In both groups, somatic symptoms (MRS) indicated mild urogenital symptoms 
(MRS) and psychological symptoms (MRS) and for total score moderate 
symptoms (MRS) at baseline (Table 8). Depressive symptoms (MADRS) 
indicated mild depression in both groups at baseline (Table 8). 
  
Women’s health in midlife - a person-centered approach in primary care  
 
60 
    Table 8. Baseline characteristics (n=110) 
  Intervention group 
  n=55 
Control group 
n=55 
Age (y)a,b 50 (3.4) 50 (47-52) 50 (3.1) 51(48-53) 
Education n (%)b 
Primary/ Secondary school (< 12 y) 
Tertiary school (>12 y) 









     
 Be in work, n (%) b 45 (82)  47 (86)  
     
 Living with a partner, n (%) b 51 (93)  47 (86)  
     
Average MRS scorec,b     
Somaticd 3..9 (2) 3 (1-6)b 4.5 (2) 5 (2-6)b 
Urogenitale 2.2 (2) 2 (0-3) 2.9(2) 2 (1-4) 
Psychologicalf 4.1 (4) 4 (1-6) 3.5 (3) 3 (1-5,3) 
Total 10 (9) 9 (4-15) 11 (11) 11 (7-15) 
Depression scoreg,b 8.3 (6.7-10) 6 (5.8) 8.3 (6.6-9.9) 7 (6.0) 
a Age in years.   
b First figure mean values (SD) second figure median (interquartile range).   
c Subscale and total Menopause Rating Scale (MRS) scoring. The reference values for the symptoms are follow: > 8 (somatic),  
> 6 (psychological), > 3 (urogenital) and >16 (total MRS) was defined as severe. Degree of severity of the MRS and its  
domains indicated; Total score; No, little (0–4), Mild (5–8), Moderate (9–16), Severe (17+), Psychological domain; No, little (0–1), 
Mild (2–3), Moderate (4–6), Severe (7+), Somatic domain; No, little (0–2), Mild (3–4); Moderate (5–8), Severe (9+),  
Urogenital domain; No, little (0), Mild (1), Moderate (2–3), Severe (4+).            
d Somatic symptoms - hot flushes, heart discomfort, sleeping problems and muscle and joint problems. 
e Urogenital symptoms - sexual problems, bladder problems and vaginal dryness. 
f Psychological symptoms - depressive mood, irritability, anxiety and physical and mental exhaustion. 
g Montgomery-Asberg Depression Rating Scale (MADRS) scoring. First figure mean (SD), second figure median (interquartile range).  International standards; 0-6 p no 






Differences between the groups four months after 
treatment. 
At the four-month follow-up, the intervention group experienced a reduction 
in somatic, urogenital, and psychological symptoms (MRS) and depressive 
symptoms (MADRS) while the control group experienced the opposite. No 
statistically significant differences between groups in changed symptoms were 




Table 9.  Changes in menopausal symptoms and depression during four months. 
 
 Mean change SDb P valuec 
 IGa CGa IG CG T test M&W MWT 
Menopausal 
Symptoms        
 Somatice  -0.13 +0.22 1.5 1.9 0.30 0.15 0.23 
 Psychologicale -0.13 +0.040 2.5 2.4 0.73 0.86 0.82 
 Urogenitale -0.15 -0.080 1.8 1.7 0.84 0.41 0.32 
 Total score -0.43 +0.42 4.1 4.1 0.30 0.29 0.46 
Depressive 
symptomsf 
-0.44 +0.10 5.0 4.8 0.58 0.48 1.0 
a Number of women providing complete answers to both questionnaires. In Intervention group (IG) n= 54 and in Control group 
(CG) n = 55. 
s Standard deviation of mean. 
c P value for comparison of change between groups. T test= students t test; M&W = Mann Whitney´s test; MWT = Mann 
Whitney´s test using transformed data. 
e MRS questionnaires with sub scales 
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Result Study III  
Sixty-five percent (n = 71/110) of the women in Study I could be followed up 
after 6 years (Figure 3). The mean value for age was 50 (SD 3.1) at first 
assessment and background data are presented in Table 10. 63% of the women 
(34/54) were still menstruating. Information on menstruation due to 
contraceptive treatments with hormones, hysterectomy or not, provided a clear 
statement that menstruation had ceased in 24% (17/71).  
 
 
Table 10. Participant Characteristics at First Assessment (n= 71) 
 
 Mean (SD) Median (IR) N (%) 
Age (y)a 50 (3.1)   
Education (y)b       
 Primary school (< 9)   15 (21) 
 Secondary school (10-12)   31 (44) 
 Tertiary school (>12)   25 (35) 
Work status/ Employment statusb    
Currently working/studyingc        61 (86) 
Sick leave full-time    0 (0.0) 
 Sick leave part-time   0 (0.0) 
Disability pension (full-time)    3 (4.0) 
Disability pension (part-time)   2 (3.0) 
Unemployed full-time   5 (7.0) 
Unemployed part-time    0 (0.0) 
Family statusb    
  Living with a partner   66 (93) 
  Children at home    17 (24) 
Still menstruatingb,d   34 (63) 
Average MRS scoree    
 Somatic  4.3 (3.0) 4.0 (2-6)  
 Urogenital 2.4 (2.5) 2.0 (0–4)     
 Psychological   3.7 (3.1) 3.0 (1-6)   
 Total MRS 10 (6.9) 9.0 (0-15)  
Average depression scoref,g 7.3 (5.5) 6.0 (3-11)  
a First figure mean value (SD)  
b n (%) 
c Work more than one hour a week 
d 34/54 are still menstruating. Information is missing in 17 women. 
e Subscale and total Menopause Rating Scale (MRS) scoring. First figure mean (SD) second figure 
median (25th and 75th percentile). Degree of severity of the MRS and its domains indicated; 
Psychological domain; No, little (0–1), Mild (2–3), Moderate (4–6), Severe (7+), Somatic 
domain; No, little (0–2), Mild (3–4), Moderate (5–8), Severe (9+), Urogenital domain; No, little 
(0), Mild (1), Moderate (2–3), Severe (4+), Total score; No, little (0–4), Mild (5–8), Moderate 
(9–16), Severe (17+). 
f Montgomery-Asberg Depression Rating Scale (MADRS) scoring. First figure mean (SD) second 
figure median (25th and 75th percentile). International standards; 0-6 p no depression, 7-19 p, 
mild depression, 20-34 p moderate depression, >34 p severe depression.  






Cardiovascular symptoms at the 6-year follow-up  
Medication for hypertension was reported by 39 % (28/71). Three women 
reported hypertension but were not medicating. Four women were 
hypertensive during pregnancy. Five women stated myocardial infarction or 
cerebral haemorrhage. 
Changes in health at the 6-year follow-up 
At baseline the women reported moderate symptoms in MRS urogenital as well 
as psychological symptoms while somatic symptoms were reported as mild 
symptoms (Table 11). At the 6-year follow-up the severity of symptoms 
decreased in MRS somatic, mean changes, −0.23 (SD 2.5), urogenital score 
−0.52 (2.5) and total score −3.5 (5.6) while psychological symptoms (MRS) + 
0.52 (3.0) and depressive symptoms (MADRS) + 0.38 (4.3) increased (Table 
11). Four of 71 women stated part-time sick leave at six years compared with 
none at baseline. 
 
11.Changes from baseline to the 6-year follow-up (n= 71)   
Family status    
 Children at home -59 %   
Being in worka -3 %   
Menopausal Symptomsb    
 Somatic -0.23 (2.5)  
 Urogenital  -0.52 (2.5)  
 Psychological +0.52 (3.0)  
 Total MRS -3.5  (5.6)  
Depressive Symptomsc,d +0.38 (4.3)  
a Paid work at least one hour per week  
b Menopause Rating Scale (MRS) subscale: Somatic symptoms - hot flushes, heart 
discomfort, sleeping problems and muscle and joint problems, Psychological 
symptoms - depressive mood, irritability, anxiety and physical and mental 
exhaustion, Urogenital symptoms - sexual problems, bladder problems and vaginal 
dryness, Total score - all subscales added. Higher score indicates more severe 
symptoms. Values are mean change (standard deviation) 
c Montgomery-Asberg Depression Rating Scale (MADRS) scoring.  Higher score 
indicates more severe symptoms. 
d, Information is missing in 5 women (66/71). 
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Predictors for good health at the 6-year follow-up 
Living with a partner and having tertiary education were the most important 
baseline predictors for health after six years (Table 12, 13 and 14). Having 
tertiary education was significantly associated with poorer mental health 
(SF36-MCS) 0.16 (CI 0.034–0.74) (p=0.019), vitality (SF36-VT) 0.18 (CI 
0.035–0.87) (p=0.033), (CI 0.035–0.87), and social role functioning (SF36-SF) 
0.12 (CI 0.28–0.50) (p=0.0051), (Table 12, 13 and 14). Living with a partner 
(yes/no) was significantly associated with increased physical role functioning 
(SF36-RF) 32 (CI 1.9–530) (p =0.016), social role functioning (SF36-SF) 21 
(CI 1.3–320) (p= 0.031) and emotional role functioning (SF36-RE) (p=0.017) 
29 (CI 1.8–460) (Table 12, 13 and 14).   
 
Work ability at baseline predicted work ability after six years (Table 12, 13 
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value indicates better perceived health. The Swedish version of the 
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present) to 4 (1=mild; 2= moderate; 3=severe; 4=very severe). The MRS total 
score is the sum of obtained scores for each sub-scale. Severe menopausal 
symptoms were defined as values equal to or above 9 (somatic), 7 
(psychological), 4 (urogenital), and 17 (total) (127, 128).  
 
The Alcohol Use Disorders Identification Test (AUDIT) (IV) 
The AUDIT was used to identify alcohol consumption, drinking behavior and 
risk habit (129). The AUDIT is self-administrated containing ten items 
categorized into three domains: consumption, addiction, and alcohol-related 
harm. Scores above the cut-off limit of 6 points for women indicate risky 
drinking habits (129).   
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Table 12. Prognostic factors for good health, workability and presence of hypertension at 6-year follow-up 
      Mental Healtha Physical Healtha Work ability Hypertensionb 
 (n=69) MCS SF36 
≥ 50 
(n=69) PCS SF36 
          ≥ 50b 
(n=71) (n=71) 
Predictors p-value Effect sizec p-value Effect sizec p-value Effect sizec p-value Effect sizec 
Aged 0.0056 1.5 (1.1-1.9) 0.67 0.96 (0.78-1.2) 0.46 1.1 (0.83-1.5) 0.13 1.2 (0.96-1.4) 
Tertiary education 0.019 0.16 (0.034-0.74) 0.54 0.65 (0.17-2.6) 0.73 0.71 (0.10-4.8) 0.53 1.3 (0.40-4.4) 
Work abilitye 0.66 0.60 (0.061-5.8) 0.017 21 (1.7-250) 0.0025 51 (4.0-670) 0.023 0.12 (0.018-0.85) 
Living with a partner  0.12 9.4 (0.56-160) 0.75 1.5 (0.13-17) 1.0 0.00 (0.00-.∞) 0.80 1.1 (0.10-13) 
Children at home 0.61 1.6 (0.28-8.3) 0.41 2.0 (0.39-11) 0.47 2.5 (0.22-28) 0.26 0.51 (0.11-2.4) 
Depressionf 0.027 0.15 (0.027-0.81) 0.012 0.16 (0.037-0.67) 0.50 2.2(0.22-22) 0.88 1.1 (0.30-4.3) 
MRS         
Somaticg 0.95 1.1 (0.090-13) 1.0 1.0 (0.12-8.4) 0.44 0.34 (0.22-5.3) 0.57 0.55 (0.071-4.2) 
Psychologicg  0.0069 0.035 (0.0032-0.40) 0.93 1.  (0.23-5.1) 0.065 0.11 (0.011-1.1) 0.27 2.0 (0.45-9.2) 
Urogenitalg 0.47 1.9 (0.34-10) 0.71 1.3 (0.32-5.3) 0.32 4.1 (0.26-12) 0.84 0.96 (0.25-3.7) 
Active interventionh 0.66 0.74 (0.19-2.8) 0.99 1.0 (0.29-3.4) 0.54 1.8 (0.27-12) 0.26 2.0 (0.61-6.3) 
Nagelkirke R square  0.53  0.36  0.49  0.26 
Hosmer-Lemeshow test 0.88  0.35  0.29  0.49  
Area Under Curveg  <0.001 0.87 (0.78-0.95) <0.001 0.81 (0.70-0.91) <0.001 0.87 (0.77-0.98) <0.001 0.76 (0.64-0.87) 
Omnibus test of model 0.00006  0.019  0.0005  0.12  
a Cut of norm for Swedish women 45-54 years, SF36 
b The part of the women stated having hypertension. 
c Effect size is Odds Ratio and (95 % CI)  for all predictors.  First figure is p-value, second figure is predicted probability and CI, the odds ratio increase in score value. 
d Odds Ratio for an increase in age of one year between 45-55 years.  
e Working  at least one hour/week. 
f Montgomery-Asberg Depression Rating Scale (MADRS) score  > 7 indicating at least mild  depression. Information is missing in 5 women (66/71). 
g Menopause Rating Scale and total Menopause Rating Scale (MRS) scoring.  Somatic symptoms - hot flushes, heart discomfort, sleeping problems and muscle and joint problems; Psychological 
symptoms - depressive mood, irritability, anxiety and physical and mental exhaustion; Urogenital symptoms - sexual problems, bladder problems and vaginal dryness.  Higher score indicates more 
severe symptoms. 





The Hospital Anxiety and Depression Scale (HADS) (IV) 
To examine anxiety and depressive symptoms, HADS was used (123). The 
HADS consists of 14 items, seven items for anxiety (HADS-A) and seven for 
depression (HADS-D) graded on a 4-point scale (0 and 3 points) where higher 
scores indicate a higher level of symptoms. The cut-off score of 8 is suggested 
to indicate possible clinical anxiety and depression (124). The questionnaire 
has good reliability and validity (124).  
 
The Short-Form health survey (SF-36) (III, IV) 
For health-related quality of life, SF-36 was used (125). The SF-36 consists of 
eight sub-scales: Physical Functioning (PF), Role-Physical (RF), Bodily Pain 
(BP), Mental Health (MH), Role-Emotional (RE), Vitality (VT), General 
Health (GH) and Social Functioning (SF). Scores for the sub-scales are 
between 0-100, a higher value indicates better perceived health. Two summary 
scores present an overall health index of mental and physical health (range 0–
100): the Physical Component Summary (PCS) including PF, RP, BP, GG and 
the Mental Component Summary (MCS) including VT, SF, RE, MT. A higher 
value indicates better perceived health. The Swedish version of the 
questionnaire shows reliability and validity (125). 
 
The Menopause Rating Scale (MRS) (I, II, III, IV) 
The MRS was used to evaluate the prevalence and severity of menopausal 
symptoms and assess health-related quality of life in ageing women. The 
instrument is a self-administrated questionnaire developed in the early 1990s 
by Heinemann and validated in Sweden and has been translated into 25 
languages (126). MRS consists of eleven items, categorised into three sub-
scales reflecting; somatic symptoms - hot flushes, chest discomfort (irregular 
heart rhythm or feeling extra heartbeats), sleeping problems and muscle and 
joint problems; psychological symptoms - depressive mood, irritability, 
anxiety, and physical and mental exhaustion; and urogenital symptoms - sexual 
problems, bladder problems and vaginal dryness. Item ranged from 0 (not 
present) to 4 (1=mild; 2= moderate; 3=severe; 4=very severe). The MRS total 
score is the sum of obtained scores for each sub-scale. Severe menopausal 
symptoms were defined as values equal to or above 9 (somatic), 7 
(psychological), 4 (urogenital), and 17 (to al) (127, 128).  
 
The Alcohol Use D sorders Identification Test (AUDIT) (IV) 
The AUDIT was used to identify alcohol consumption, drinking behavior and 
risk habit (129). The AUDIT is self-administrated containing ten items 
c tegorized into three domains: consumption, addiction, and alcohol-related 
harm. Scores above the cut-off limit of 6 points for women indicate risky 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The Hospital Anxiety and Depression Scale (HADS) (IV) 
To examine anxiety and depressive symptoms, HADS was used (123). The 
HADS consists of 14 items, seven items for anxiety (HADS-A) and seven for 
depression (HADS-D) graded on a 4-point scale (0 and 3 points) where higher 
scores indicate a higher level of symptoms. The cut-off score of 8 is suggested 
to indicate possible clinical anxiety and depression (124). The questionnaire 
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The Short-Form health survey (SF-36) (III, IV) 
For health-related quality of life, SF-36 was used (125). The SF-36 consists of 
eight sub-scales: Physical Functioning (PF), Role-Physical (RF), Bodily Pain 
(BP), Mental Health (MH), Role-Emotional (RE), Vitality (VT), General 
Health (GH) and Social Functioning (SF). Scores for the sub-scales are 
between 0-100, a higher value indicates better perceived health. Two summary 
scores present an overall health index of mental and physical health (range 0–
100): the Physical Component Summary (PCS) including PF, RP, BP, GG and 
the Mental Component Summary (MCS) including VT, SF, RE, MT. A higher 
value indicates better perceived health. The Swedish version of the 
questionnaire shows reliability and validity (125). 
 
The Menopause Rating Scale (MRS) (I, II, III, IV) 
The MRS was used to evaluate the prevalence and severity of menopausal 
symptoms and assess health-related quality of life in ageing women. The 
instrument is a self-administrated questionnaire developed in the early 1990s 
by Heinemann and validated in Sweden and has been translated into 25 
languages (126). MRS consists of eleven items, categorised into three sub-
scales reflecting; somatic symptoms - hot flushes, chest discomfort (irregular 
heart rhythm or feeling extra heartbeats), sleeping problems and muscle and 
joint problems; psychological symptoms - depressive mood, irritability, 
anxiety, and physical and mental exhaustion; and urogenital symptoms - sexual 
problems, bladder problems and vaginal dryness. Item ranged from 0 (not 
present) to 4 (1=mild; 2= moderate; 3=severe; 4=very severe). The MRS total 
score is the sum of obtained scores for each sub-scale. Severe menopausal 
symptoms were defined as values equal to or above 9 (somatic), 7 
(psychological), 4 (urogenital), and 17 (total) (127, 128).  
 
The Alcohol Use Disorders Identification Test (AUDIT) (IV) 
The AUDIT was used to identify alcohol consumption, drinking behavior and 
risk habit (129). The AUDIT is self-administrated containing ten items 
categorized into three domains: consumption, addiction, and alcohol-related 
harm. Scores above the cut-off limit of 6 points for women indicate risky 
drinking habits (129).   
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Predictors for good health at the 6-year follow-up 
Living with a partner and having tertiary education were the most important 
baseline predictors for health after six years (Table 12, 13 and 14). Having 
tertiary education was significantly associated with poorer mental health 
(SF36-MCS) 0.16 (CI 0.034–0.74) (p=0.019), vitality (SF36-VT) 0.18 (CI 
0.035–0.87) (p=0.033), (CI 0.035–0.87), and social role functioning (SF36-SF) 
0.12 (CI 0.28–0.50) (p=0.0051), (Table 12, 13 and 14). Living with a partner 
(yes/no) was significantly associated with increased physic l role functioning 
(SF36-RF) 32 (CI 1.9–530) (p =0.016), social role functioning (SF36-SF) 21 
(CI 1.3–320) (p= 0.031) and emotional role functioning (SF36-RE) (p=0.017) 
29 (CI 1.8–460) (Table 12, 13 and 4).   
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(SF36-MCS) 0.16 (CI 0.034–0.74) (p=0.019), vitality (SF36-VT) 0.18 (CI 
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Work ability at baseline predicted work ability after six years (Table 12, 13 
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Result Study IV  
Three-hundred and sixty-eight women 45-60 were randomised into four groups 
either Group I (GE) (n=91), Group II (GE/PCS) (n=91), Group III (PCS) 
(n=93) or Group IV (CG) (n=93) (Figure 1, Study IV). The mean values for 
age were 52 (SD 7.0) (Table 1, Study IV). Half of the women had tertiary 
school education 188/368 (51%), most were working (94%), living with a 
partner (79%), had children living at home (55%), and had non-risky alcohol 
consumption (90%) (Table 1, Study IV). Used MHT were reported from 15 % 
(56/368) divided in systemic administration 7% 26/368 and local 
administration 8 % (30/368). The study population at first assessment are 
presented in Table 1, Study IV.  
Changes in health at 6 and 12 months. 
At the 6-month follow-up, changes from baseline indicated a reduction in 
somatic, psychological, and urogenital symptoms (MRS) in all four groups 
(Table 2a, Study IV). Mental health was improved in all four groups (SF36, 
HADS, s-ED, PSS-14, MADRS) (Table 2a, Study IV). 
At 12-months changes from baseline indicated a reduction in somatic, 
psychological symptoms (MRS) in all four groups. For the sub-scale urogenital 
symptoms (MRS) a reduction of symptoms were seen in group 2,3,4 (ITT-
analyses) (Table 2b, Study IV). Mental health had improved or stabilized 
(SF36, HADS, s-ED, PSS-14, MADRS). At 12 months, a decrease in SF36 
domain’s physical function (PF) and bodily pain (BP) and SF36-PCS) was 
shown in Group 1 (Table 2b, Study IV). 
The menopause status “had not had a period in > 12 months” was reported by 
half of the women 149/289 (49 %), had regular menstruation and 18 % 
(52/289) had irregular bleeding within the last 12 months from 12% (36/289). 
Hormonal contraceptives that may influence the bleeding pattern were reported 
from 12 % (36/289) (Table 2b, Study IV). MHT at the 12-month follow-up 
was reported by 28% 80/289 (Table 2b, Study IV).  
Effect of GE and PCS at 6 and 12 months.  
At the 6-month follow-up, a statistically significant positive effect in somatic, 
urogenital symptoms and MRS total score was showed in GE. At the 12-month 
follow-up this effect was lost but a positive effect was shown in mental health 
(SF36-MH, s-ED) (Table 3 and supplemental Tables 1-4, Study IV). At the 6-
month follow-up, a statistically significantly positive effect in psychological, 
urogenital symptoms, MRS total score and mental health (SF-36-MH) was 
shown in PCS. At the12-month follow-up this effect was further reinforced 
(Table 3 and supplemental Tables 1-4, Study IV). When GE and PCS were 
combined additionally positive effects were shown in SF36-PF and MADRS 





The studies in this thesis have described and identified factors associated with 
the transitional period in women between 45 and 60 years of age and have 
shown positive effects on, somatic, urogenital and mental symptoms, and 
quality of life through a person-centered intervention in PHC. 
At the first assessment the diversity and severity of symptoms was elucidated, 
and poor mental health was shown to be the most common symptom. More 
severe depression symptoms and increasing age were associated with more 
severe symptoms according to MRS (I). After six years it appears that midlife 
women living with a partner had a better chance for maintaining good health. 
Tertiary education was shown to be associated with poor mental health at a 6-
year follow-up (III).  
The effect of GE and PCS in PHC context showed that PCS on topics related 
to women 45-60 improved health-related quality of life, and reduced mental, 
urogenital, somatic, and stress-related symptoms with an effect lasting at least 
12 months. These results suggest that PCS can improve health for midlife 
women and could be an effective intervention in PHC for improving women’s 
health (IV). 
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Methodological aspects  
Study design and study population (I, II, III, IV) 
The present thesis was based on two observational studies and two RCTs. A 
cross-sectional study (I) was conducted to evaluate prevalence and severity of 
somatic, urogenital, and psychological symptoms measured with MRS in 
women 45-55 consulting PHC (I). A cross-sectional design could be 
considered when the purpose is to estimate prevalence and describe the 
severity of symptoms. All women were invited to a 6-year follow-up where 
65% of participants could be included (III). The recruitment of participants in 
these studies aimed to reflect clinical practice.   
Two RCTs (II, IV) were performed to assess the effect of an intervention 
performed in a PHC setting. In Studies II and IV, due to the character of the 
intervention the participants and investigators were not blinded to group 
allocation since they participated in the intervention.  
Previous studies use different terms for menopause transition (16, 73, 77, 116, 
132, 133). In the present thesis, the terms for the transitional period for women 
were; women aged 45–55 (III), middle aged (I, IV), menopausal women, and 
women during the menopause transition (II).  
One hundred and thirty-one women were included in Studies I-III (Figure 3). 
These three studies were based on the same population, which is considered a 
strength as the women could be followed-up for a period of six years.  
In Study IV participants were recruited by advertisement, which may have 
selected motivated women to participate in the study. However, approximately 
half of the included women had consulted PHC during the last two months at 
baseline suggesting that most of these women would have been included if we 
instead had used a consecutive enrolment in PHC. In this study, the women 
were followed up after 12 months, which is a longer follow-up period than in 
previous studies evaluating group education on topics related to middle-aged 
women (111-116). 
Gender (I, II, III, IV)  
This thesis includes only women, which may be considered a limitation, but 
the aim of the included studies was not to explore gender differences. The 
purpose of the included studies was to illuminate symptoms, identify 
prognostic factors for future health and interventions targeting topics relevant 







Measurements (I, II, III, IV) 
Validated self-reported questionnaires were used for assessment of symptoms, 
health, and quality of life in all included studied (I, II, III, IV). The 
questionnaires AUDIT, SF36, HADS, s-ED, PSS-14, MADRS and MRS used 
in this thesis have shown good validity and reliability in PHC population (118, 
120, 125, 126, 129, 134, 135).  
This thesis (I, II, III, IV) used the questionnaires MRS to measure quality of 
life and gain a profile of symptoms. The interventions were based on the MRS 
topics. MRS has been shown to be a better age- and condition-specific quality 
of life questionnaire for middle-aged women compared with SF-36 (42). 
Moreover, latest Swedish guidelines for menopause recommend using MRS 
(59). The SF-36 was included whereby it is a generic health-related quality of 
life measurement, which makes it possible to compare different populations 
regardless of condition.   
MRS measures the severity of ageing symptoms and their impact on quality of 
life (42).  Previous studies state that it can be used in PHC for the assessment 
of quality of life in a standardised way to guide treatment options (36). 
Furthermore, the MRS is showed to be a useful measure of treatment effect 
(27, 36).   
In this thesis, a cut off score of 17 points in MRS was used for categorising 
women having severe menopausal symptoms, which has been previously 
recommended (126). How to define a cut off score for severe symptoms to treat 
menopausal symptoms and according to the woman’s own perception are under 
discussion (36).   
Interventions (II, IV) 
In this thesis two RTCs were included. The educational programs structured in 
this thesis (II, IV) were based on the MRS sub-scales psychological, 
urogenital, and somatic. To our knowledge, this thesis is the first patient 
education program based on MRS items in Sweden in PHC on topics related 
to menopause transition to women aged 45-60 (II, IV). 
In Study II, the control group was offered the same educational program as the 
intervention group after responding to Questionnaire II. Since the control 
group also received the intervention it is not possible to follow the effect of the 
educational program over time.  
In Study IV, a two-factor design with four parallel arms and a high percentage 
follow-up, 78 % at six months and 79 % at twelve months, which is the main 
strength of this RCT.  
Evaluating a person-centered individual or group educational intervention 
concerning issues relevant to midlife women with stress-related symptoms, is, 
as far as we know, the first in Swedish PHC. The contents of the interventions 
did not focus on hormones, but targeted natural ageing and topics related to the 
transition period for women 45-60. 
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Statistical analysis (I, II, III, IV)  
In Study I, baseline values for a population of women 45-55 for prevalence of 
somatic, psychological and urogenital symptoms, and to evaluate factors 
associated with severe symptoms were measured with a multivariable logistics 
regression. To better complement the results and get an overview of the factors 
associated with severe symptoms a nomogram (Figure 4) was used and showed 
results of severe menopausal symptoms with an MRS > 17 points, age, and 
depression symptoms >7 points.  
 
The MRS and MADRS were used in all the included studies. Both include 
items measuring anxiety and depression. However, MADRS contains several 
items without corresponding items in MRS. There is a significant overlap for 
MRS and MADRS, but also important differences. Spearmann’s correlation 
coefficient was carried out to reinforce the fact that between MADRS ≥7 and 
MRS psychological sub-scale >6 the correlation is only 0.39 (n=108), which 
does not prohibit performing a regression analysis with these variables (I). 
Before logistic regression a multicollinearity test was carried out by exploring 
the value of the tolerance and VIF between independent variables (I, III, IV). 
Study II has three possible approaches to analyse ordinal data, since treating 
observations measured by an ordinal scale, according to statisticians, vary (II). 
Using parametric methods such as a Student t-test, if data are normally 
distributed, are recommend by some statisticians. While others recommend 
that ordinal data always must be analysed using non-parametric methods. 
According to some statisticians the lack of equidistant scale steps such as for 
ordinal data is contradictory to the assumptions of simple subtraction, and 
consequently a change over time cannot be calculated. (II). We analysed the 
data using all three methods to ensure that this choice would not lead to 







Somatic, psychological, and urogenital symptoms 
and factors associated with severe symptoms in 
women (Study I). 
 
Mental health 
Study I indicated that among mental symptoms the most frequent and severe 
reported where depression symptoms (67 %), of which 17% reported “severe-
very severe” symptoms. Physical and mental exhaustion were reported in 73 
%, with ten percent reporting “severe-very severe” (Table 6). Depression and 
mental exhaustion are often related to prolonged high stress levels without 
adequate recovery. Psychosocial factors for the women have shown 
association with mental health and an impact on women’s quality of life (13). 
Mental illness is the most common cause of long-term sick leave among 
midlife women in Sweden (6, 138). Early prevention for mental illness and 
mental exhaustion is recommended to reduce future sick leave (138-140). 
Hence, focus on preventive factors on women’s mental health is important. 
 
Sleeping problems 
Sleeping problems together with depressive symptoms were the most prevalent 
(67 %, respectively), and of these 17% were reported severe to very severe 
symptoms (Table 5). Sleeping problems are a strong factor for the risk of 
developing mental ill-health affecting quality of life (15, 107). The incidence 
of sleep disorders increased for midlife women (63). Due to the high incidence 
of sleep problems and the strong link to mental illness, women's quality of 
sleep should be actively studied. 
 
Pain 
Musculoskeletal pain and stiffness are symptoms that usually affect midlife 
women (6, 141), and were one of the most common reported (70%), of which 
11% had severe to very severe symptoms (Table 6). Muscle and joint pain are 
common causes of poor sleep quality and quality of life (21, 65, 142). In 
addition, pain and mental illness, are common causes of long-term sick leave 
in midlife women (3, 33, 143).  
 
Cardiovascular symptoms 
The risk for cardiovascular disease (CVD) increases from 45–55 years of age 
(57, 144). The present study indicated almost half of the women had 
cardiovascular problems and in accordance with previous studies reported 
heart discomfort (Table 6) (57, 67, 145). Moreover, risk may increase for 
mental illness from increasing stress factors and sleep problems (63, 72, 146). 
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Thus, increasing women’s awareness of any cardiovascular risk factors is 
important (2, 57). 
 
Urogenital symptoms and local oestrogen deficiency 
A majority of women reported sexual problems, bladder symptoms and vaginal 
dryness of moderate severity (Tables 5 and 6). Moreover, bladder symptoms 
and vaginal dryness were reported from approximately half of the women 
(Table 6), which is consistent with previous studies (75). Local oestrogen 
deficiency (LOD) resulting in urinary incontinence (UI), vaginal dryness, 
burning and pain during intercourse, itching and frequent urinary tract 
infections, is a common cause of urogenital problems. Previous studies show 
that LOD symptoms and changes in women’s daily lives and relationships may 
cause sexual problems and decreased sexual desire (76, 147, 148). Urogenital 
symptoms for midlife women have a strong impact on mental health and 
quality of life. Consequently, it is important to increase awareness of the 
symptoms of oestrogen deficiency, and of adequate treatment and relief of 
symptoms, and how various events and relationships in daily life impact health. 
 
Early detection important but difficult 
High prevalence of mental illness was shown in this study which is in line with 
previous studies (6, 13, 41, 55, 141). Furthermore, this study indicated that the 
prevalence of depression and menopausal symptoms seems to increase with 
age (Table 7 and Fig. 4). A previous study showed that long-term symptoms 
before seeking PHC were associated with delayed recovery, emphasizing the 
importance of identifying these symptoms. However, it can be difficult to 
detect depression symptoms while one third of women with depression 
symptoms only mention somatic symptoms when consulting PHC (141). 
 
The transition between 45 and 55 years of age 
The transition between 45 and 55 is a natural change in a woman's life. Some 
see this period as natural, while others see it as undesirable. This period 
includes major psychosocial changes such as children leaving home, ageing, 
parental care, changes in social relationships, and work (5, 13, 15, 38, 138, 
149). Thus, social support can be valuable during this period (15). Therefore, 





Group education for women about the menopause 
transition to improve their physical and mental ill-
health (Study II).  
Previous studies show that women’s mental ill health and risk for long-term 
sick leave increases during menopause transition (55, 150). Therefore, 
education on a subject related to menopause transition could provide valuable 
health prevention input to women 45-55. This study indicated that it was 
possible and practical to organize group education around the topic of 
menopausal symptoms. For this group education the resources required were 
small. This intervention could be implemented as part of PHC’s responsibility 
for health promoting activities. 
 
Timing of education  
Early detection and awareness of the symptoms of stress and poor mental 
health are important because delay involves risk for a prolonged recovery 
process (28). Previous studies have shown that girls in puberty maintain 
positive attitudes towards menstruation and the body if valuable information is 
provided just before the first menstruation (44). It is possible that early 
information about menopause transition is just as relevant for women about to 
enter menopause. 
Prognostic factors for future mental, physical and 
urogenital health as well as work ability in women 
45–55 (III).  
This study (III) showed that better health 6 years later seems to be associated 
with living with a partner as compared to being single for women aged 45-55 
with an impact on physical, social, and emotional role function (SF36) (Tables 
12, 13 and 14). 
Moreover, tertiary education seems to be associated with an increased risk of 
reduced mental health, vitality, and social role function (SF36) (Tables 12, 13 
and 14). The level of education appears to be an important aspect to consider 
in health prevention work for women with poor mental health. 
The ability to participate in social interaction in and outside the home as well 
as in daily life and work are important for mental health and preventing 
emotional problems (40).  
The extent to which women live in an equal, friendly, harmless, and safe 
environment with their partner are social health factors and related to women's 
health. The ability to cope and solve problems and maintain a balance between 
work and leisure with time for recovery are other factors related to women's 
health.  Previous studies show that women often have a higher level of 
education than men but a lower average income. Poorer general health and 
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anxiety problems were experienced more by women than by men (33). The 
results of our study seem to support that tertiary education was associated with 
future poorer mental health, lower vitality, and poorer social role functioning. 
Therefore, it is important for women to maintain an awareness of a healthy 
balance in life and to have realistic goals at work and at home. This 
intervention focused highly on social health factors impacting a woman’s 
quality of life. 
 
Tertiary education  
Previous studies have often shown that mental problems and perceived poor 
health were attributed to people with less education compared to those with 
greater (88, 151). Women with less education had more sick leave compared 
to women with tertiary education (151). However, a dramatic change has 
occurred where the largest increase in sick leave has been in the group with 
longer education in the last 5 to 10 years (152). Factors appear to be high 
demands at work and at home, as well as psychosocial factors leading to 
increasing stress-related diagnoses in those with a tertiary education compared 
to women with a lower education (38, 40). The increased ill health of the highly 
educated women can also be related to greater exposure to certain risks, such 
as patriarchal systems that hinder women's progress in work, unreasonable 
burdens caring for others, imbalance between traditional administrations and 
realities in life and violence and sexual harassment at work (19, 33). Previous 
studies show a high increase of long-term sick leave caused by stress-related 
illness and depression among female academics (152). 
This study appears to support the fact that tertiary education is associated with 
future poorer mental health, lower vitality, and lower social role functioning. 
Therefore, it is important to maintain women’s awareness of a healthy balance 
in life and to have realistic goals socially and at work.  
 
Living with a partner 
Important factors for good mental health were social support and a successful 
marriage (153).  Communication in a relationship may be a key to good health 
(154). Hence, it is important to be aware and inquire into marital status and 
partner relationships and the quality of relationships when discussing health 
issues with midlife women.  Better mental health and quality of life were 
shown in happily married midlife women compared with women unhappily 
married and single women (153, 154). Higher marital quality and social 
support were shown to be associated with better health and a lower risk of 




The effect of group education and person-centred 
support in a primary health care context on mental 
health issues and quality of life (Study IV).  
This study is the first in Swedish PHC evaluating an individual or group 
educational intervention concerning issues relevant to middle-aged women 
with stress-related symptoms. The contents of PCS and GE do not focus on 
hormones but target natural ageing and topics related to middle-aged women. 
In this RCT the intervention was led by district nurses and midwives working 
in PHC who often meet middle-aged women with stress-related symptoms. 
The interventions GE and PCS contained mental and psycho-social topics 
related to common psycho-social factors and events in the period of midlife as 
these factors have been shown to have a strong association with psychological 
symptoms and mental health impacting women’s quality of life (5, 15, 16, 27)  
The interventions also included discussions about urogenital health such as 
symptoms and the course of local oestrogen deficiency due to a strong 
correlation to quality of life impacting the women’s health. Menopause VMS 
such as hot flushes and sweating was discussed in the intervention as it affects 
60-80% on middle-aged women and has been strongly related to reduced 
quality of life physically and psychosocially, impacting sleep and overall 
wellbeing (16, 61). In addition to the topic of VMS, these interventions also 
consisted of a discussion on the subject of cardiovascular risk-and health 
factors, and sleep problems. For midlife women, cardiovascular symptoms, 
and the incidence of CVD are increasing (57, 72, 144). 
 
A person-centered approach was used in the interventions based on the 
women’s narratives, needs and beliefs. The district nurse and midwife 
encouraged the women to use coping strategies for the process of changing 
thoughts and behavior to impact health and quality of life.  
 
The PCS improved health and quality of life in middle-aged women at the short 
and long-term follow-up. The improvement was shown in all analyses (CC, 
PP, ITT) for urogenital, psychological, and total MRS, stress symptoms (PSS-
14) and mental health (SF26-MH) at 6 and 12 months. At the 6-month follow-
up depressive symptoms increased for GE and PCS (Table 3, Study IV). For 
PCS the result was the opposite at 12 months showing a decrease in depressive 
symptoms (MADRS). This result might be explained by the need for time to 
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symptoms (MADRS). This result might be explained by the need for time to 
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Health-related quality of life  
These interventions led to improved quality of life measured with MRS. MRS 
could be used to show the impact of menopausal symptoms on quality of life 
and evaluate the severity of symptoms associated with menopause and assess 
treatment effect. This is an important effect since the signs and symptoms can 
affect women’s quality of life by up to 80%, and about 42% reported symptoms 
as very serious. These interventions included dialogues reflecting somatic 
symptoms (sleep, hot flushes, heart symptoms and pain), urogenital symptoms 
(UI, LOD, sexual problems) and psychological symptoms (depression 
symptoms, irritability, difficulty concentrating, and mental and physical 
exhaustion) and psychosocial factors due to a strong correlation with quality 
of life and impact on women’s health (5, 17, 27).  
 
Mental Health  
This study indicated improved mental health in both GE and PCS at the 12-
month follow-up, which is an important result whereby women have a higher 
risk for mood changes (16, 27) as well during the menopause transition (5, 15). 
Experience of psychosocial factors has shown to have a much stronger 
association with psychological symptoms than the stages of menopause (1). 
PHC treats almost 70% of patients diagnosed with depression and stress-
related disorders (7, 109).  
Decreased mental illness might reduce the risk or development of a CMD, and 
the risk of experiencing life as uncontrollable and overloaded, and perceived 
mental stress, which has been shown in previous studies (119). GE and PCS 
contained mental and psychosocial topics related to midlife women due to 
psychosocial factors showing a strong association with psychological 
symptoms and mental health, and impacting women’s quality of life (5, 15, 16, 
27, 77).  
 
Urogenital health  
The intervention PCS improved urogenital symptoms, which is an important 
result since urogenital symptoms have a strong correlation with decreased 
quality of life and mental illness (16, 73). Previous studies have shown that 
symptoms of local oestrogen deficiency were experienced by half of all 
postmenopausal women (75, 76). Moreover, urinary incontinence (UI) is 
another common urogenital health problem among women and where 
approximately 50% of midlife women are affected by UI and the severity of 






Somatic health  
PHC offers basic treatment for women with VMS and these interventions GE 
and PCS included dialogues on somatic symptoms in a person-centered 
approach. For midlife women, cardiovascular symptoms, and the incidence of 
CVD are on the rise (57, 72, 144) and previous studies have shown improved 
mental and physical health after person-centered education for patients with 
CVD risk (104, 108, 117). However, in this study somatic symptoms measured 
with MRS were not improved after 12 months. 
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District nurse role in primary health care  
The interventions in this thesis are based on health prevention in women's 
natural ageing from 45-60 years of age, which is within the district nurse's 
competence and area of responsibility (88). The district nurse plays a key role, 
working independently, with responsibility for health prevention work in PHC 
based on a person-centered approach. She is a support for people of all ages 
"from the cradle to the grave", with naturally ageing and development, 
regardless of condition, where psychosocial aspects are an important factor 
(84, 87). Thus, the result of this thesis, including the use of MRS when 
screening for menopause symptoms and important prognostic factors for later 
health in middle-aged women and the intervention PCS, should be 
implemented using the district nurse’s competence for improving women’s 
health. 
In summary, the district nurse's work is an opportunity to work with people of 
all ages, with varying health conditions, and promote the patient's physical and 
mental health, and social well-being based on a health-promoting, person-
centered, and health pedagogical approach, with a perspective on natural 






The conclusion of this thesis is that the included studies have described and 
identified factors associated with the transition period in women between the 
ages of 45 and 60, identified prognostics factors for later work ability and 
quality of life as well as positive effects on health-related quality of life, 
physical, urogenital, and mental symptoms of a person-centered intervention 
in PHC. 
The diversity and severity of symptoms can be elucidated with MRS, and 
mental ill health symptoms appears to be the most common, and more severe 
depression symptoms and increasing age were associated with more severe 
symptoms according to MRS.  
It appears that midlife women living with a partner have a better chance to be 
in good health and having tertiary education was shown to be associated with 
poorer mental health after 6 years.  
Individual person-centered support (PCS) on topics related to women 45-60 
improved health-related quality of life, and reduced mental, urogenital, 
somatic, and stress-related symptoms with an effect lasting at least 12 months. 
These results suggest that PCS can improve health for midlife women and 
could be an effective intervention in PHC for improving women’s health. 
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This thesis concluded that poor mental health was shown to be the most 
common symptom in midlife women and more severe depression symptoms 
and increasing age were associated with more severe symptoms according to 
MRS. To prevent severe menopausal symptoms, we recommend that 
cardiovascular risk factors, musculoskeletal symptoms, urogenital problems, 
sleeping problems and mental health should be actively penetrated in midlife 
women aged attending PHC. Using the questionnaire MRS can generate a 
profile of menopause symptoms to evaluate the severity of ageing related 
symptoms and their influence on quality of life. Future studies could evaluate 
preventive intervention for women consulting PHC before the age of 45. 
Living in a good relationship with a partner seems to be a strong factor for 
good perceived health, while tertiary education seems be a risk factor for 
poorer mental health 6 years later. To gain a deeper knowledge a qualitative 
study could illuminate this factor.  
An individual person-centred support (PCS) on topics related to the transition 
period in midlife women improved health-related quality of life, and reduced 
physical, urogenital, mental, and stress-related symptoms with an effect lasting 
at least 12 months. Future research could evaluate an implementation process 






Jag vill uttrycka min varma och uppriktiga tacksamhet till alla som på olika 
sätt har bidragit till att möjliggöra denna avhandling.  
 
Ett stort varmt tack till mina handledare Lena Nordeman, Ronny 
Gunnarsson, Gun Rembeck och Dominique Hange som under dessa år 
stöttat, inspirerat, kommit med kloka förslag, tränat mig till att reducera och 
kondensera text. Jag är så tacksam för att jag haft er som handledare, utan er 
ingen avhandling. Tusen tack.  
 
Tack, Lena Nordeman, min huvudhandledare, för ditt enorma tålamod, 
stöttning, ditt engagemang och att du generöst tagit dig tid och delat med dig 
av din stora kunskap. Din positiva inställning och ödmjukhet, när du säger ”Jag 
har ett förslag”. Du har tagit dig tiden att läsa mina manuskript, gett mig 
konstruktiv kritik, gett mig kloka råd och feedback. Tack för att du är en 
omtänksam, varm, klok och ödmjuk forskare och handledare och introducerat 
mig i SPSS förtrollade värld. Utan dig hade denna avhandling inte varit möjlig. 
 
Tack, Ronny Gunnarsson, min biträdande handledare, för ditt otroliga 
tålamod, att du generöst delat med dig av din oerhörda kunskap. Tack för att 
du tagit dig tid, kondenserat, gett mig konstruktiv kritik, utmärkta råd och 
feedback, med orden ”Jag har ett förslag”. Tack för att du på ett fantastiskt 
pedagogiskt sätt förklarar vetenskapsmetodikens och statistikens underbara 
värld. Utan din stöttning, hade denna avhandling inte varit möjlig. 
 
Tack, Gun Rembeck, min biträdande handledare. Du var min första 
handledare och följt mig under hela resan och delat med dig av din stora 
kunskap. Du är alltid lika glad, positiv, uppmuntrande och du har trott på mig 
och varit ett ovärderligt stöd under hela min forskarutbildning. Utan din tro på 
mig, hade denna avhandling inte varit möjlig. Tack för att du generöst tagit dig 
tid för mig under mina doktorandstudier, gett mig konstruktiv kritik, gett mig 
goda råd och feedback. 
 
Tack Dominique Hange, min biträdande handledare, för att du under dessa år 
alltid gett mig uppmuntrande ord, kloka råd, delat med dig av din stora kunskap 
och feedback. Du har haft en lugnande inverkan. Utan din stöttning, hade 
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Jag vill också särskilt tacka 
 
Gunilla Strömme min kära forskarkollega, medförfattare och vän, tack för ditt 
stöd och uppmuntran under mina doktorandstudier. Tack för vår resa 
tillsammans och att vi har haft möjlighet att forma en utbildning till kvinnor 
”mitt i livet”. Det har varit en spännande tid med nya upplevelser, utmaningar, 
erfarenheter och många skratt. Utan dig hade denna avhandling aldrig varit 
möjlig.  
 
Stort tack till Ewa Askerdal, distriktsköterskekollega och vän, för att du har 
inspirerat mig genom ditt sätt att samtala med kvinnor, om att våga fråga, att 
”sticka hål på ballongen”, att få kvinnor att må bättre för att hantera livet. Med 
stor framgång och stor uppskattning från kvinnor med ditt engagemang har du 
inspirerat kvinnor till att tro på sig själva och göra förändringar i livet. Utan 
din medverkan och delaktighet hade denna avhandling aldrig varit möjlig. 
 
Mark Rosenfeld, för värdefull engelskspråkig redigering och för din 
tillgänglighet under slutet av granskningen av avhandlingsarbetet och med 
alltid lika gott humör och vänlighet.  
 
Irene Svenningson och Åsa Premberg, tack för att ni varit medförförfattare 
och varit stöttande, inspirerande och gett mig god feed-back. 
 
Tack till Tanja Franson och Evelina Kortzon på FoU-enheten i Borås för 
alltid lika vänligt stöd och praktisk hjälp. 
 
Min närmaste chef Spiros Lappas, stort tack, det har alltid bara funnits 
löningar hos dig och du har gjort det möjligt och beviljat mig arbetstid för mina 
doktorandstudier. 
 
Gunn Karlsson, min vän, tack för din uppmuntran, ödmjukhet, positiva 
inställning till min forskning och ditt varma stöd. 
 
Tack till mina kollegor på FoU Centrum Södra Älvsborg för uppmuntran, 
inspiration och stöd under mina doktorandstudier. 
 
Alla mina vänner, tack för stöttning, påhejande och härliga skratt under mina 
doktorandstudier. 
 
Mina arbetskamrater på Närhälsan Södra Torget Borås, tack för er 
uppmuntran under mina doktorandstudier. 
 





Institutionen för folkhälsa och samhällsmedicin, enheten för 
primärvården, för att ha tagit emot mig som doktorand och för professionellt 
stöd under min utbildning. 
 
Nationella Forskarskolan i Allmänmedicin (finansierad av svenska 
Forskningsrådet) för forskarutbildning, stimulering och nätverkande. 
 
Tidigare chefer och överordnade chefer inom Närhälsan för att gett mig 
möjligheten att göra denna avhandling på arbetstid.  
 
Ekonomiskt stöd för denna avhandling erhölls från Regionala FoU-rådet 
Västra Götaland, Lokala FoU-rådet Södra Älvsborg Borås, FOUU 
Välfärd Sjuhärad, Statliga stimulansmedel; Kvinnors hälsa-Primärvård, 
ALF-medel (Avtal om Läkarutbildning och Forskning) beviljats ALF-tjänst 
för legitimerade hälsoprofessioner på doktorandnivå. 
 
Sist och mest av allt min familj. Tack Arne, min älskade man för ditt oändliga 
tålamod, stöttning och kärlek under mina doktorandstudier. Tack mina 
underbara barn med familjer, Caroline och Amir, Catrin och Carl och 
barnbarnen Elin och Alva, Peter och Olivia och barnbarnet Alice, Johan och 
Parya, Kalle och Sofia, Johanna och Nisse och barnbarnen Viktor och Nilas. 
Ni är alla de viktigaste människorna i mitt liv. Utan er kärlek och stöd hade 
denna avhandling aldrig varit möjlig. 
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